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ABSTRACT 
 
Conversion between two growth stages, tachyzoites and bradyzoites, plays a key 
role in the pathogenesis of Toxoplasma gondii.  Current studies aimed to elucidate the 
roles of lactate dehydrogenase (TgLDH) and argonaute (TgAgo) in relation to conversion.  
The over-expression of TgLDH1 or TgLDH2 did not change the overall enzymatic 
activity or increase growth of tachyzoites.  However, a significant in vitro differentiation 
into bradyzoites was detected.  These findings suggest that TgLDH1 and TgLDH2 have 
important physiological functions, in addition to being glycolytic enzymes and 
differentiation markers.  Furthermore, altered TgAgo expression increased bradyzoite 
formation and interfered with the parasite’s ability to successfully perform double 
stranded induced gene silencing.  The change in TgAgo expression also affected the 
levels of putative dicer proteins suggesting a direct correlation between TgAgo and an 
RNAi-like mechanism.  
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Chapter I 
Introduction 
 
1.1 Significance of Toxoplasma gondii and disease   
Toxoplasma gondii is an intracellular protozoan parasite and a member of the 
Apicomplexa phylum, which is characterized by the presence of apical secretory 
organelles including micronemes, rhoptries, and dense granules (Dubey et al., 1998).  T. 
gondii causes significant disease in a variety of mammals and birds and is known to infect 
approximately one third of the world’s population, which may lead to the development of 
toxoplasmosis. 
T. gondii infections can be acquired either through ingestion of viable tissue cysts 
in under-cooked meat or through ingestion of water contaminated with oocysts from 
infected cat faeces (Frenkel, 1973; Dubey et al, 1970).  Initial infection of individuals 
with a healthy immune system, are normally asymptomatic because the rapidly 
multiplying tachyzoite stage of the parasite can be cleared by the host immune response.  
When infection is acquired during pregnancy however, in utero toxoplasmosis can occur, 
resulting in harm to the fetus such as abortion, severe birth defects, or fetal death 
(Guerina et al., 1994).  Tachyzoites can undergo a stage interconversion into the slowly 
multiplying, encysted bradyzoites, which can remain dormant for the lifespan of the host, 
causing chronic toxoplasmosis (Ferguson et al., 2002; Lindsay et al., 1991).  
Toxoplasmosis can prove fatal when infected patients become immuno-compromised, 
such as HIV/AIDS patients (Wong and Remington, 1993; Luft and Remington, 1992), 
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wherein the bradyzoites are released from the tissue cysts and differentiate back into 
tachyzoites giving rise to a recurrent infection and making this an opportunistic parasite.  
The ability of the parasite to interconvert between these two stages is thought to play a 
key role in the pathogenesis of the parasite.  The process of interconversoin in humans 
and other non-definitive hosts is poorly understood (Reiter-Owona et al., 2000).  To date, 
no effective treatment for chronic toxoplasmosis has been developed.  Therefore, studies 
of T. gondii in cell culture facilitate the search for possible drug targets and the 
development of preventative strategies and therapeutic agents for toxoplasmosis.    
 
1.2 Toxoplasma gondii as an apicomplexan model 
 The apicomplexan parasites include many pathogenic protozoans, such as 
Plasmodium and Cryptosporidium, which cause a variety of diseases in humans.  For 
instance, the Plasmodium parasite is known to infect human red blood cells causing 
malaria, a serious and possibly fatal disease (Cowman and Crabb, 2002), while 
Cryptosporidium causes a diarrhoeal illness called cryptosporidiosis that is also 
associated with immuno-compromised individuals (Abrahamsen et al., 2004).  Studies of 
these parasites have proven challenging due to the difficulty of culturing and maintaining 
them in the laboratory.  T. gondii however, is the most experimentally tractable parasite 
since it is easily propagated and cultured (Kim and Weiss, 2004).  Thus, T. gondii has 
become a major model for the study of apicomplexans due to the ease of genetically 
manipulating the parasite for the study of basic biology and host response (Roos et al., 
1994; Black and Boothroyd, 1998).  The 80 Mb haploid genome of T. gondii consists of 
14 chromosomes.  Recent sequencing projects have provided a great amount of 
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information that has been deposited into the T. gondii database further enhancing research 
efforts (ToxoDB: http://www.toxodb.org; Kissinger et al., 2003).        
 
1.3 Genetic manipulations of Toxoplasma gondii 
A variety of tools have been developed for genetically manipulating T. gondii, 
thus enhancing the study of gene functions and molecular events.  In order to introduce 
DNA and RNA into T. gondii, electroporation has become a method of choice, in which 
an electric current is applied to the parasite creating pores in the membrane, allowing for 
the nucleic acids to be incorporated.   
 
1.3.1 Transient and stable transfections 
Transient gene expression occurs when the transforming plasmid lacks a T. gondii 
origin of replication, or fails to be maintained in the genome resulting in gene expression 
that lasts for a short amount of time (Roos et al., 1994).  Reporter genes such as β-
galactosidase (LacZ), chloramphenicol acetyltransferase (CAT), and luciferase (Luc) 
have been employed to indicate that the plasmid introduction was successful, with highest 
efficiency occurring when the expression is driven by T. gondii promoters such as those 
of surface antigens, rhoptry proteins, and β-tubulin (Roos et al., 1994; Soldati and 
Boothroyd, 1995).   
Stable transformation, on the other hand, results from either homologous or 
random integration of the transgenes, and leads to parasites that permanently express the 
selectable marker.  Transformation vectors containing sequences from the dihydrofolate 
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reductase-thymidylate synthase gene (DHFR-TS) have been developed for random 
integration (Donald and Roos, 1994).   
 
1.3.2 Endogenous selectable markers for stable transfections  
There are a variety of selectable markers that can be used for generating stable 
transformants.  Two important selectable markers that are highly utilized in the present 
studies include the hypoxanthine-xanthine-guanine phosphoribosyltransferase (HXGPRT) 
and uracil phosphoribosyltransferase (UPRT) genes, which are part of the purine and 
pyrimidine pathways, respectively, and provide the substrates for DNA and RNA 
biosynthesis (Iltzsch, 1993; Chaudhary et al., 2004). 
 
1.3.2.1 Hypoxanthine-xanthine-guanine 
phosphoribosyltransferase 
 Similar to many intracellular pathogens, T. gondii does not contain a de novo 
purine nucleotide biosynthesis pathway.  Therefore, the parasite relies on the purine 
salvage pathway to provide purine nucleotides that are required for growth (Krug et al., 
1989).  Hypoxanthine-xanthine-guanine phosphoribosyltransferase (HXGPRT, E.C. 
2.4.2.8), an essential gene of the purine salvage pathway, catalyzes the conversion of 
hypoxanthine, xanthine, and guanine into inosine monophosphate (IMP), xanthine 
monophosphate (XMP), and guanine monophosphate (GMP), respectively (Fig. 1.1).  In 
the absence of HXGPRT or xanthine, IMP dehydrogenase can synthesize XMP.  When 
utilizing HXGPRT as a positive selectable marker; mycophenolic acid (MPA) and 
xanthine are added to the culture media.  IMP dehydrogenase is inhibited by MPA, thus 
synthesis of XMP and GMP, which is required for parasite survival, is prevented.  
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However, parasites containing HXGPRT can utilize the added xanthine to synthesize 
XMP and survive.  Therefore, parasites lacking the HXGPRT gene, RHΔHX, are 
electroporated with plasmids containing the HXGPRT gene and therefore, only parasites 
that incorporate and express HXGPRT can survive under MPA and xanthine selection.  
Furthermore, HXGPRT can also be utilized for negative selection.  In this case, HXGPRT 
catalyzes the conversion of 6-thioxanthine (6-TX) in the media, into 6-thioxanthosine-5’-
phosphate, which causes toxicity to the parasite, thus only parasites that lack the 
HXGPRT gene can survive (Chaudhary et al., 2004; Donald and Roos, 1993).     
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Figure 1.1  Purine salvage pathway of Toxoplasma gondii.  The dominant enzymes 
of the purine salvage pathways are adenosine kinase (AK) and hypoxanthine-xanthine-
guanine phosphoribosyltransferase (HXGPRT).  The other enzymes are numbered: (1) 
adenosine deaminase; (2) purine nucleoside phosphorylase; (3) adenine deaminase; (4) 
AMP deaminase; (5) IMP dehydrogenase; (6) GMP synthetase; (7) adenylosuccinate 
synthetase; (8) adenylosuccinate lyase.  HC represents host cell cytoplasm; PV refers to 
the parasitophorous vacuole; PC refers to the protist cytoplasm.  This image was modified 
from Chaudhary et al., 2004. 
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1.3.2.2  Uracil phosphoribosyltransferase 
Uracil phosphoribosyltransferase (UPRT, E.C. 2.4.2.19) is an enzyme responsible 
for the incorporation and conversion of uracil into uracil monophosphate (UMP) in the 
pyrimidine salvage pathway (Fig. 1.2) (Schwartzman and Pfefferkorn, 1981).  Since T. 
gondii is capable of synthesizing pyrimidines de novo, UPRT is not an essential enzyme 
for the parasite.  UPRT has the ability to recognize pyrimidines, as well as cytotoxic 
analogs of pyrimidines.  Thus, UPRT can also incorporate and convert 5-fluorouracil into 
5-fluorouridine which is further synthesized into 5-fluorouridine monophosphate (F-
dUMP) which prevents the synthesis of thymidine monophosphate, resulting in lethality 
to the parasite (Iltzsch and Tankersley, 1994).  Generation of parasites lacking the UPRT 
gene allows for survival, since the 5-fluorouracil cannot be incorporated and metabolized.  
Mammalian cells do not have the ability to take up uracil from the media, therefore 
studies involving UPRT can also be utilized for measuring the parasite’s ability to 
incorporate radioactively labelled uracil, [5,6-3H]-uracil in order to measure viability 
(Pfefferkorn and Pfefferkorn, 1977) and gene regulation (Al-Anouti et al., 2003). 
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Figure 1.2  De novo pyrimidine biosynthesis and pyrimidine salvage pathways of 
Toxoplasma gondii.  The synthesis of UMP, the precursor for pyrimidines, is shown 
where the UPRT enzyme (1) is part of the salvage pathway.  This image was obtained 
from Fox and Bzik, 2002. 
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1.4 Toxoplasma gondii parasite types and host cells 
 Molecular analysis suggests that all currently identified strains of Toxoplasma 
gondii can be classified into three common clonal lineages; types I, II, and III (Howe and 
Sibley, 1995; Sibley and Boothroyd, 1992).  Type I strains, such as RH and GT1, are 
highly virulent strains that cause 100% lethality in mice with a single infectious organism 
and have a limited ability to form cysts in culture and in animals.  Also, Type I strains are 
fairly uncommon, where only a small group of congenital toxoplasmosis patients and 
opportunistic infections in AIDS patients have been identified.  On the other hand, Type 
II strains, such as ME49 and PLK, and Type III strains, such as VEG, are less virulent in 
mice and cause lethality with more than 1000 parasites.  Type II strains have been found 
to be the most prevalent strain in clinical isolates and may cause mild infection in healthy 
individuals but severe disease in AIDS patients (Khan et al., 2009; Sibley, 2009).  
Furthermore, type I strains are commonly used in laboratories for in vitro studies due to 
their rapid replication rate and efficiency of lysing host cells, allowing for isolation of 
large amounts of tachyzoites.   
The proliferative form of the parasite is the tachyzoite, which can be maintained in 
many mammalian cells.  The infection ability of tachyzoites is greater in adhesive cell 
types rather than in suspension cultures, possibly due to the higher probability of contact 
between parasites and adherent monolyaers as compared to suspended cells.  Therefore, 
human foreskin fibroblasts (HFF) are typically used in routine cell culture.  HFF cells are 
convenient due to their ease of passage and their morphology which consists of a large 
plasma membrane allowing for multiple cycles of replication of T. gondii to occur before 
lysis.  Finally, HFF cells are fairly resistant to metabolic inhibitors due to their inability to 
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grow past confluency, thus allowing for drug selection of transfected parasites (Roos et 
al., 1994).  
 
1.5 General cell biology of Toxoplasma gondii  
 
1.5.1 Sexual cycle in the definitive host 
Toxoplasma gondii has a complex life cycle involving two phases, the sexual 
cycle in the feline definitive host and the asexual cycle in any intermediate host, such as 
cattle and humans, which is summarized schematically in Figure 1.3.  The sexual cycle 
occurs only in intestinal epithelial cells and begins with the feline ingesting tissue cysts 
from infected animals such as rats (Frenkel, 1973).  The parasites are then released in the 
digestive system where they proceed through gametogenesis which consequently leads to 
the formation of a diploid zygote known as an oocyst.  The oocysts are excreted in the 
feces, and upon exposure to oxygen and ambient temperature, sporogony occurs wherein 
two meiotic divisions and one mitotic division produce eight haploid sporozoites divided 
into two sporocysts which remain stable and infectious for months to a year in the soil, 
even in harsh climates (Frenkel, 1973).   
 
1.5.2 Asexual cycle in intermediate hosts 
Infectious oocysts in the soil or viable tissue cysts in undercooked meat provide 
an entry into humans and animals.  Upon entry, the sporozoites or bradyzoites infect the 
intestinal epithelium and differentiate into tachyzoites, a process also known as 
interconversion.  The tachyzoites travel throughout the body via the blood stream, causing 
initial infection by T. gondii which is typically asymptomatic or may cause mild flu-like 
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symptoms.  The asexual cycle occurs within the host cell where the parasite multiplies by 
endodyogeny forming two daughter cells in each division, eventually causing the host cell 
to rupture and allowing the parasite to infect neighbouring cells (Sheffield and Melton, 
1968; reviewed in Black and Boothroyd, 2000).  After the host’s immune response is 
triggered, the tachyzoites convert into the slowly multiplying bradyzoites where they are 
protected within tissue cysts for the remainder of the host’s lifespan (Ferguson et al., 
2002; Lindsay et al., 1991).   
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Figure 1.3 The life cycle of Toxoplasma gondii.  The life cycle of T. gondii consists 
of a sexual cycle within intestinal cells of felines, and an asexual cycle that occurs in 
mammals, birds, and virtually any nucleated cell.  Infection is often acquired through 
accidental ingestion of eliminated oocysts.  Acute infection is represented by the quickly 
replicating tachyzoites, while chronic infection is representative of encysted bradyzoites 
that remain dormant for the lifespan of the host.  This image was obtained from Dubey, 
1986.   
 
 
 
 
 
 
 
13 
 
1.5.2.1  Tachyzoites 
The asexual cycle of T. gondii consists of two different stages of the parasite 
including tachyzoites and bradyzoites, which differ in many aspects.  Tachyzoites are the 
rapidly dividing form of the parasite which cause initial infection.  They are often 
crescent shaped with an approximate length of 6 μm and width of 2 μm.  Tachyzoites 
have the ability to infect almost any nucleated cell by attaching to the host cell membrane 
and directly penetrating the cell where they become encased in the parasitophorous 
vacuole (PV) composed of membranes from both the parasite and host cell (Dobrowolski 
and Sibley, 1996).  The asexual cycle occurs within the host cell where the parasite 
multiplies by endodyogeny forming two daughter cells in each division (Sheffield and 
Melton, 1968).  Tachyzoites continue to replicate until they eventually rupture the host 
cell and are released, where they can infect neighboring cells. 
 
1.5.2.2  Bradyzoites 
Tachyzoites differentiate into bradyzoites upon a response from the host’s 
immune system.  Bradyzoites are the slowly multiplying form of the parasite that generate 
tissue cysts within the host, defining the chronic stage of infection.  Bradyzoite tissue 
cysts are commonly found in the central nervous system as well as in the muscles ranging 
from a size of 50 μm to 70 μm containing 1000-2000 bradyzoites that are crescent shaped 
with a size of 7 μm by 1.5 μm (Dubey et al., 1998; Fortier et al., 1996; Sims et al., 1989).  
The cyst wall, composed of ß-(1,4) linked N-acetylglucosamine residues called chitin, a 
derivative of glucose, surrounds the bradyzoites and is responsible for protecting the 
parasite from the host’s immune response.  This cyst wall is easily identified in culture by 
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fluorescently labeled lectins in Dolichos biflorus which bind the glycoprotein CST1 
(Zhang et al., 2001; Boothroyd et al., 1997). 
Ultrastructurally, bradyzoites differ from tachzyoites since brazyzoites have a 
posteriorly located nucleus, honeycombed rhoptries, and several amylopectin granules for 
glucose storage; whereas tachyzoites have a centrally located nucleus, electron dense 
rhoptries and very few amylopectin granules (Ferguson et al., 1987, 1989).  Furthermore, 
bradyzoites are more slender than tachyzoites, and tachyzoites are more sensitive to 
destruction by proteolytic enzymes (Jacobs et al., 1960).  The differences in structure and 
organelle location can be observed in Figure 1.4.    
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Figure 1.4  Schematic representation of T. gondii tachyzoites and bradyzoites.  
The asexual cycle consists of two life stages; the tachyzoites (left) and the bradyzoites 
(right), which differ both structurally and metabolically.  Tachyzoites are quickly 
replicating while bradyzoites are the slower multiplying, encysted form found during 
chronic infection.  This image was obtained from Dubey et al., 1998. 
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1.5.2.3  Tachyzoite to bradyzoite interconversion 
Interconversion between the two developmental stages is often associated with 
altered environmental conditions and is typically a factor in pathogenesis.  The reversible 
process of interconversion between tachyzoites and bradyzoites plays a key role in the 
pathogenesis of T. gondii because chronic infection is characterized by the differentiation 
of tachyzoites into bradyzoites found in tissue cysts, and recurrence of infection is 
characterized by the reconversion of bradyzoites into tachyzoites in immuno-
compromised individuals (Dubey et al., 1998).  The mechanisms behind the 
interconversion process are poorly understood.   
There are many limitations in obtaining large amounts of encysted bradyzoites in 
vivo, therefore, mimicking the interconversion in vitro allows one to study the process in 
detail and gain a better understanding of the mechanisms involved.  The stress exerted by 
the host’s immune response triggers the formation of bradyzoites, thus a variety of stress 
conditions have been applied to culture bradyzoites in vitro.  The in vitro cysts have been 
shown to be similar to in vivo cysts isolated from brains of chronically infected mice in 
that they are both resistant to pepsin treatment (Popiel et al., 1996; Knoll and Boothroyd, 
1998).   
In order to initiate differentiation in vitro, that is, conversion from tachyzoites to 
bradyzoites, a variety of methods can be utilized that exert stress on the intracellular 
parasites.  These methods include culturing the infected monolayers in the presence of 
basic (pH 8.0-8.2) media (Soete et al., 1994; Weiss et al., 1995; Weiss and Kim, 2000), 
interferon (IFN)-γ (Bohne et al., 1993), mitochondrial inhibitors (Bohne et al., 1994; 
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Tomavo and Boothroyd, 1995), a trisubstituted pyrrole molecule (compound 1) (Radke et 
al., 2006) and by increasing the levels of cyclic nucleotides (Kirkman et al., 2001).   
The most common method used to initiate in vitro differentiation is to increase the 
pH of the culture media to a pH of 8.0-8.2 and culture under ambient CO2, since 
bradyzoite formation is most consistent and frequent under this condition (Soete et al., 
1994; Weiss et al., 1995).  Alkaline culturing media can result in a direct effect on T. 
gondii, as well as an indirect effect from host cells under stress, which subsequently 
triggers stage conversion.  The major benefit of using alkaline media is that the 
bradyzoites formed have the most defined bradyzoite phenotype that can be achieved in 
culture (Radke et al., 2006). 
It has been observed that proinflammatory cytokines including interferon-gamma 
(IFN-γ) are required for resistance against T. gondii (Suzuki et al., 1988; Bohne et al., 
1993).  These cytokines are related to mechanisms involving production of nitric oxide 
(NO) and tryptophan starvation, which may lead to a limitation in parasite replication, 
thus leading to formation of bradyzoites.  Production of nitric oxide in T. gondii is 
associated with its ability to react with the iron-sulfur centers present in proteins that are 
part of the electron transport chain in aerobic respiration, thus halting the process and 
leading to differentiation.  Furthermore, sodium nitroprusside (SNP), a nitric oxide donor, 
has also been shown to induce bradyzoite formation (Bohne et al., 1994).     
Other drugs and chemicals have shown ability to initiate bradyzoite formation in 
vitro.  In particular, inhibitors of mitochondrial function such as antimycin A (inhibitor of 
the electron transport chain), myxothiazol (inhibitor of coenzyme Q-cytochrome c 
reductase in the electron transport chain), and oligomycin (inhibitor of mitochondrial 
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ATP synthetase function) result in a reduction in growth and formation of bradyzoites 
(Bohne et al., 1993, 1994; Soete et al., 1993, 1994).   
 Nutrient deprivation has also been utilized in differentiation studies. T. gondii 
lacks the enzymes required for de novo arginine biosynthesis, thus it requires arginine 
from the host cell.  Consequently, arginine starvation has shown to lead to bradyzoite 
formation.  Finally, increasing cyclic nucleotides can also result in differentiation in vitro.  
It has been determined that increasing the levels of cyclic GMP (cGMP) and cyclic AMP 
(cAMP) leads to differentiation.  This is conjunction with using the NO donor sodium 
nitroprusside, since this also triggers increased levels of cAMP, and in turn leads to 
differentiation (Kirkman et al., 2001).  Therefore, using the above mentioned methods, it 
is possible to study the differentiation process in vitro to gain a better understanding of 
the mechanisms involved.   
 
1.6 Energy production and consumption in Toxoplasma gondii  
Intracellular parasites of the Apicomplexa phylum, including Toxoplasma gondii, 
rely on eukaryotic host cells for survival.  The exclusive replication within host cells 
suggests that the metabolism of the host is important for parasite survival and that 
parasites have evolved metabolic pathways that reflect their intracellular nature.  Thus, 
studies of these pathways are important for determining possible targets for drug 
development (Kim and Weiss, 2007).   
Toxoplasma gondii not only changes its rate of multiplication and morphology 
between the tachyzoites and bradyzoites, but it also changes its metabolism upon changes 
in environmental conditions.  Tachyzoites rely on both aerobic and anaerobic respiration, 
whereas bradyzoites rely heavily on anaerobic respiration.  As previously noted, certain 
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mitochondrial inhibitors such as antimycin A, myxothiazol, and oligomycin result in an 
increase in expression of antigens specific to the bradyzoite stage which further suggests 
a relation between mitochondrial function and stage conversion (Bohne et al., 1993, 
1994; Soete et al., 1993, 1994).  Also, some enzymes of the tricarboxylic acid (TCA) 
cycle are not present in bradyzoite parasites (Denton et al., 1996), providing further 
evidence that mitochondrial oxidative phosphorylation is likely impaired in bradyzoites 
and that bradyzoites rely heavily on glycolysis for energy production (Fig. 1.5).  
Moreover, interference with the electron transport chain occurs when activated 
macrophages produce nitric oxide leading to an increase bradyzoite formation (Bohne et 
al., 1994) which further suggests that the host may attempt to remove the parasite by 
interfering with the energy generating pathways in order to control proliferation.  In order 
to compensate, the parasite converts into the slow-replicating, less energy-consuming, 
encysted form, thus increasing its viability.  Furthermore, T. gondii bradyzoites contain 
amylopectin, a polymer of glucose, granules that are not present in high amounts in 
tachyzoites, providing energy storage for the encysted and dormant bradyzoites.  It has 
been suggested that amylopectin granules provide energy for the conversion back into 
tachyzoites by the degradation into glucose which provides metabolic substrates and 
intermediates for either glycolysis or mitochondrial oxidative phophorylation (Kim and 
Weiss, 2007). 
 Although tachyzoites and bradyzoites have equally functional glycolytic 
pathways (Denton et al., 1996), a unique set of glycolytic enzymes are responsible for the 
energy production of each differentiation stage (Fleige et al., 2007; Tomavo, 2001).  With 
the exception of hexokinase and glucose-6-phosphate isomerase, each glycolytic enzyme 
is coded by at least two independent genes whose mRNAs are differentially regulated 
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(Fleige et al., 2007).  It has been shown that three isoenzymes of glycolysis, lactate 
dehydrogenase, glucose 6-phosphate isomerase, and enolase, are stage-specifically 
expressed in T. gondii (Yang and Parmley, 1997; Dzierszinski et al., 1999). 
Since glycolysis is the predominant energy-generating pathway in bradyzoites, the 
stage-specific expression of these enzymes suggests that they contain features that are not 
available with the tachyzoite isoenzymes.  It is also likely that the isoenzymes are 
required for the adaptation of the parasite to differing environments and there may be a 
relationship between energy production and stage conversion.  
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Figure 1.5 The metabolism of Toxoplasma gondii.  Lactate dehydrogenase is shown 
as the last committed enzyme of glycolysis in T. gondii.  This schematic also 
demonstrates the relationship between glycolysis and amylopectin granules.  This image 
was obtained from Weiss and Kim, 2007. 
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1.7 Toxoplasma gondii lactate dehydrogenase  
T. gondii contains two isoforms of lactate dehydrogenase (TgLDH1 and TgLDH2, 
L-lactate:NAD+ oxidoreductase, EC 1.1.1.27), the last committed enzyme of the 
glycolytic pathway (Fig. 1.5).  The expression of genes encoding TgLDH1 and TgLDH2 
are differentially regulated and commonly used as markers of the differentiation stage: 
TgLDH1 is the marker of the tachyzoite stage, while TgLDH2 is that of the bradyzoite 
stage (Yang and Parmley, 1997).  Both TgLDH1 and TgLDH2 catalyze the inter-
conversion of pyruvate to lactate and have a preference for the co-enzyme nicotinamide 
adenine dinucleotide (NAD+) (Kavanagh et al., 2004).   
The mRNA of TgLDH1 has been reported to be present in both the tachyzoite and 
bradyzoite stages, however the protein product is only found in tachyzoites, suggesting 
that the expression of TgLDH1 may occur at the post-transcriptional or post-translational 
level.  The TgLDH2 mRNA and protein product, on the other hand, are only present in 
bradyzoites, suggesting that the expression is controlled at the transcriptional level.   
TgLDH1 and TgLDH2 have 64% nucleotide sequence identity and 71.4% amino acid 
sequence identity, with predicted molecular masses of 35,550 and 35,342 Da, 
respectively, and predicted isoelectric points of 5.96 and 7.08, respectively (Yang and 
Parmley, 1997).  As compared to LDH proteins in other apicomplexan parasites, T. gondii 
LDH1 and LDH2 share 46.5% and 48.5% amino acid identity with the LDH from 
Plasmodium falciparum, respectively (Bzik et al., 1993).  Structural and biochemical 
analyses showed that the active sites of TgLDH1 and TgLDH2 carry a pentapeptide 
insertion (Kavanagh et al., 2004; Bzik et al., 1993), which is similar to the LDH in P. 
falciparum and is lacking in the human LDH isoenzyme.  T. gondii LDH2 and P. 
falciparum LDH have the same insertion (KSDKE) whereas the insertion differs in 
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TgLDH1 (KPDSE) (Yang and Parmley, 1997).  This pentapeptide insertion makes 
TgLDH1 and TgLDH2 ideal targets for the development of anti-parasitic agents to 
combat both acute and recurrent toxoplasmosis.  By binding to this pentapeptide 
insertion, small molecules/ligands would interfere with the activity of TgLDH1 and 
TgLDH2.  More importantly, the inhibition of TgLDH2 might confer a highly potent anti-
parasitic effect because the encysted and slow-replicating bradyzoites lack a functional 
TCA cycle and respiratory chain (Denton et al., 1996), and would consequently depend 
greatly on the activity of TgLDH2 for energy production under anaerobic respiration.  
Moreover, previous work showed that the physiological level of TgLDH1 and TgLDH2 
expression is required for the parasites to maintain their normal growth and to allow for 
differentiation (Al-Anouti et al., 2004).  This evidence thus indicates that the activity 
along with the temporal regulation of TgLDH1 and TgLDH2 expression could be used as 
potential drug targets.   
 
1.8 RNA biochemistry and gene regulation 
 Posttranscriptional gene silencing (PTGS), or RNA interference (RNAi), is an 
evolutionary conserved mechanism wherein RNA plays a role in sequence specific 
degradation of mRNA.  It is thought that the native role of RNAi was to inhibit 
retrotransposon movement, to silence repeated DNA sequences, and to defend against 
viral infection (Mello and Conte, 2004).  Today, RNAi has become an important tool for 
regulating gene expression and has potential for being a therapeutic technique for the 
treatment of infectious diseases and cancers. 
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1.8.1 Discovery of RNA interference 
RNA induced gene silencing is a novel gene regulatory mechanism that may 
either suppress transcription or cause sequence-specific degradation; a process known as 
posttranscriptional gene silencing or RNA interference.  Initially, PTGS was discovered 
in plants, but was quickly followed by a similar discovery in a variety of eukaryotes 
including protozoa, nematodes, insects, as well as mouse and human cell lines.  The 
initial discovery in plants occurred by a search for transgenic petunia flowers that had a 
deep purple color after over-expressing chalcone synthase, an enzyme required for 
production of anthocyanin pigments.  Unexpectedly, the transgenic petunia plants lost 
both the endogenous and transgene activity, and the phenomenon was coined 
cosuppression (Van Blokland et al., 1994; van der Krol et al., 1990; Napoli et al., 1990).  
It was later discovered that introduction of sense and antisense transgenes could initiate 
PTGS in plants and other eukaryotes (Francesco et al., 2001).   
The discovery of PTGS in plants led to studies in other eukaryotic organisms 
where the ability of double stranded RNA (dsRNA) to induce gene silencing in the 
nematode Caenorhabditis elegans was demonstrated (Fire et al., 1998).  In nematodes, 
the unc22 gene is responsible for a myofilament protein that, when present in lowered 
amounts, causes a twitching phenotype.  Researchers injected the nematode with dsRNA 
corresponding to the unc22 gene and observed the twitching phenotype that increased in 
the progeny (Fire et al., 1998).  These findings paved the way for discoveries of RNA 
interference in many eukaryotic organisms, as well as for the discovery of the proteins 
involved in the pathway, and most importantly, the use of RNAi to easily create 
knockdown mutants.   
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1.8.2 General mechanism of an RNA interference pathway 
Elucidating the mechanism of RNA interference began with genetic screens of 
Neurospora crassa, Chlamydomonas reinhardtii, Caenorhabditis elegans, and 
Arabidopsis thaliana to search for mutants defective in RNAi.  This led to the discovery 
of many essential proteins to the pathway indicated as initiators, effectors, and amplifiers.   
The process of RNAi begins with the cleavage of long double stranded RNA into 
small interfering RNAs (siRNAs) consisting of 21-25 nucleotides.  Identification in 
Drosophila of an enzyme that contains an RNaseIII domain which was known to have 
specificity for dsRNA led to the discovery of dicer (Bernstein et al., 2001).  Dicer cleaves 
dsRNAs into short uniformly sized siRNAs which contain 3’overhangs of 2 to 3 
nucleotides and 5’-phosphate and 3’-hydroxyl termini (Elbashir et al., 2001), which is 
termed the initiating step.  Dicer enzymes consist of four domains including a helicase 
domain, RNaseIII domain, dsRNA binding domain, and a PAZ domain.  The RNaseIII 
domain is responsible for the cleavage action of dicer.  The next step is the effector step, 
where the siRNAs bind an RNA-induced silencing complex (RISC), which undergoes 
activation by ATP exposing the antisense strand of the siRNA, allowing it to identify and 
cleave mRNA molecules at 10-11 nt from the 3’ terminus of the guide RNA (Elbashir et 
al., 2001) leading to mRNA degradation (Hammond et al., 2000), translational inhibition 
(Pillai et al., 2005), or heterochromatin formation (Verdel et al., 2004).  The main protein 
part of the RISC complex that is responsible for the binding to and cleaving of 
homologous mRNA is the argonaute protein, consisting of a PIWI and a PAZ domain 
(Hammond et al., 2000).  Therefore, the identification of argonaute in an organism 
implies that a mechanism similar to RNAi occurs in the organism.  Finally, mutation 
studies in Drosophila of an RNA-dependent RNA polymerase (RdRP) protein showed 
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that RNAi activity was affected, leading to evidence that this protein plays a role in 
amplifying the RNAi signal by generating dsRNA through utilization of the siRNA as 
primer molecules (Lipardi et al., 2001; Sijen et al., 2001).        
Along with siRNAs, microRNAs have been identified in many organisms such as 
D. melanogaster, C. elegans, plants, and humans, and function in RNAi pathways 
responsible for preventing mobile transposable elements from disrupting the genomes, as 
well as having important roles in development.  microRNAs are typically generated from 
single stem-loop precursor structures (Hutvágner et al., 2001).  Both microRNAs and 
siRNAs are processed by dicer proteins; however siRNAs bind the RISC complex, 
whereas microRNAs bind other microribonucleoprotein complexes, both of which 
contain a member of the PIWI/PAZ family (Fig. 1.5).  
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Figure 1.6 Pathways of post-transcriptional gene regulation.  The fates of siRNA 
derived from antisense transcription, viral infection, and transfection, and miRNA from a 
primary mRNA transcript are shown, which result in either mRNA cleavage or 
translational inhibition.  This image was obtained from Filipowicz et al., 2005. 
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1.8.3 Argonaute family of proteins 
 An important core component of the RISC complex has been identified as an 
argonaute protein that is responsible for the cleavage of mRNA transcripts guided by 
siRNAs (Song et al., 2004; Liu et al., 2004).  Argonaute proteins consist of two structural 
domains: a central PAZ domain and a C-terminal PIWI domain, where the PAZ domain 
binds siRNA and the PIWI domain cleaves mRNA.  Structural studies of argonaute from 
Pyrococcus furiosus indicated similarities between the PIWI domain and the RNase-H 
family of ribonucleases providing further evidence that argonaute is responsible for 
cleavage (Song et al., 2004).   
Along with functions in RNAi, argonaute proteins have also been shown to 
function in developmental processes of many organisms (Carmell et al., 2002; Jaronczyk 
et al., 2005).  Studies in Drosophila and C. elegans of reduced expression of argonaute 
resulted in defective germlines leading to speculation that there are evolutionarily 
conserved roles in germline stem cell maintenance (Cox et al., 2000; Tijsterman et al., 
2002).   
Studies of the role of argonaute in Trypanosoma brucei has suggested that 
protozoans contain an RNAi pathway that resembles that of multi-cellular eukaryotic 
organisms (Ullu et al., 2004). The T. brucei genome contains two argonaute genes, 
TbAgo1 and TbPiwi, where only TbAgo1 functions in RNAi (Durand-Dubief and Bastin, 
2003).  Further studies on TbAgo1 determined that it is involved in controlling siRNA 
and retrotransposon transcript levels, as well as having a role in chromosome segregation 
and mitotic spindle assembly (Shi et al., 2004; Durand-Dubief and Bastin, 2003).  
Searching genomic databases has identified both dicer and argonaute homologs in 
other protozoans.  Specifically, Toxoplasma gondii argonaute (TgAgo) has recently been 
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identified.  It was found that TgAgo is a 58 kDa protein containing a conserved PIWI 
domain, and a non-conserved PAZ domain (Fig. 1.6), that participates in double stranded 
induced gene silencing in T. gondii (Al Riyahi et al., 2006).  However, TgAgo’s role in 
either an RNA interference pathway or in other cellular pathways is still unknown.  
Therefore, further studies are required to elucidate the role of argonaute in T. gondii.    
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Figure 1.7 Alignment of Toxoplasma gondii argonaute.  Alignments of structural 
domains of T. gondii argonaute protein (TgAgo) with that of: Arabidopsis thaliana 
argonaute 1 (AtAgo1, accession number: U91995), Homo sapiens argonaute 2/EIF2C2 
(HsAgo2, accession number: NP_036286), Trypanosoma brucei argonaute 1 (TbAgo1, 
accession number: AAR10810), and Archaeoglobus fulgidus Piwi protein (AfPiwi, PDB 
ID: 1W9H). The domain locations and sizes are estimated and solid lines indicate amino 
acid sequences with no recognized domains.  This image was obtained from Al Riyahi et 
al., 2006. 
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1.9 Objectives 
I.  The current studies aimed to elucidate the role of the glycolytic enzyme lactate 
dehydrogenase (TgLDH) within the differentiation process.  To do so, transgenic 
parasites over-expressing either TgLDH1 or TgLDH2 were generated.  Phenotypical 
analyses were conducted to measure changes in growth under tachyzoite and bradyzoite 
conditions, overall TgLDH enzymatic activity, and differentiation ability to determine if 
over-expression of TgLDH’s affected any of the above process.   
II.  It was of interest to study if argonaute (TgAgo) played a role in differentiation.  A 
fusion between TgAgo and a cherry fluorescent protein was generated and over-expressed 
in T. gondii.  The differentiation ability of this strain was compared to that of a parental 
strain and a TgAgo knockout strain.  
III.  The relationship between TgAgo and a possible gene silencing pathway of T. gondii 
was studied.  The transgenic parasites containing altered expression of TgAgo were tested 
in ability to perform double stranded induced gene silencing, and as well, the expression 
of putative dicer proteins was monitored upon alterations in TgAgo expression. 
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Chapter II 
Materials and Methods 
 
2.1 Plasmid design and constructs  
2.1.1 Construction of pTUB8Myc_His_TgLDH 
The coding sequences of TgLDH1 and TgLDH2 (GenBank accession nos. 
U35118 and U23207) were amplified from pMAL_LDH1 and pMAL_LDH2 (plasmids 
obtained from Dr. S. Parmley, Palo Alto Medical Foundation) using oligonucletide 
primers, 5'LDHxNsiI: GATTTCAGAATTCGGATCC and 3'LDHxPacI: 
CCCTTAATTAAGTGCCAAGCTTAAGATC to generate PCR products with NsiI on 
their 5'-terminus and PacI on their 3'-terminus.  The PCR products were subsequently 
cloned into the Toxoplasma-expression plasmid, pTUB8Myc_His_X-HX (gift from Dr. 
D. Soldati, University of Geneva), so that the expression of TgLDH1 or TgLDH2 was 
under the control of a modified tubulin (TUB) promoter and the recombinant proteins 
were led by Myc- and His-epitope tags on their N-terminus to give ~39 kDa and ~40 kDa 
protein products, respectively.  The constructs were analyzed by restriction endonucleases 
and confirmed by nucleotide sequencing reactions. 
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2.1.2 Construction of pTUB8_TgAgo_ChFP plasmid 
The open reading frame of TgAgo (GenBank accession no. DQ196314) was PCR 
amplified using the oligonucleotide primers Nhe1on5TgAgo:  
AAAGCTAGCAAAATGATCATGCCTCCCCGAAATCG and Bgl2on3TgAgo: 
AAAAGATCTACAG AACACCATCGGGGTC to generate a fragment with NheI on the 
5’ terminus and BglII on the 3’ terminus.  The fragment was cloned into a BlueScript pkS 
plasmid (Strategene) for blue/white screening, and the correct plasmid was confirmed by 
restriction digestion using XhoI and PvuII.  The TgAgo coding sequence was obtained by 
digestion with NheI and BglII and was further cloned into the Toxoplasma-expression 
plasmid, pTub8_ChFP (Dr. John Murray, University of Pennsylvania), and verified using 
restriction digestion analysis and DNA sequencing.  The expression of TgAgo, fused to a 
cherry fluorescent protein on the C-terminal, was under the control of a modified TUB 
promoter producing a protein product of ~85 kDa. 
 
2.2 General molecular biological techniques for plasmid generation 
2.2.1 Transformation of Top10 Escherichia coli cells 
General molecular biological techniques were used for the transformation of E. 
coli cells, isolation of plasmid DNA, and restriction digestions of plasmids for 
confirmation of constructs.  Briefly, all plasmids were transformed into Top10 E. coli 
subcloning-grade competent cells by the heat shock method.  Competent cells were 
incubated with plasmid DNA on ice for 20 min, followed by heat pulsing at 42oC for 45 s, 
and incubating on ice for another 2 min.  Next, 400 µL of pre-heated Luria-Burtani (LB) 
medium (10 g/L tryptone, 5 g/L bacto-yeast extract, 10 g/L NaCl) was added, and the 
reaction was incubated for 30 min at 37oC with agitation.  The cells were then plated on 
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an LB agar plate with the appropriate antibiotic (10 g/L tryptone, 5 g/L bacto-yeast 
extract, 10 g/L NaCl, 15 g/L agar, 1mg/L antibiotic) and grown at 37oC overnight.   
 
2.2.2 Plasmid isolation by minipreps 
Plasmids were isolated by growing a bacterial colony in 3 mL of LB broth 
supplemented with antibiotic at 37oC overnight with agitation.  Half of the culture was 
centrifuged at 12,000 rpm for 1 min and the pellet was resuspended in 100 µL of 25mM 
Tris-HCl (pH 8.0), 10 mM EDTA, 200 µL of 0.2N NaOH, and 1% SDS.  Furthermore, 
150 µL of 3 M NaOAc (pH 5.2) was added, the sample was mixed by inversion, and 
centrifuged at 12,000 rpm for 15 min.  The clear supernatant was combined with 400 µL 
of TE-buffered phenol:chloroform:isoamyl alcohol (25:24:1), vortexed for 30 s, and 
centrifuged at 12,000 rpm for 5 min at room temperature.  The plasmid DNA was 
precipitated with 800 µL of 95% ethanol and centrifuged at 12,000 rpm for 15 min at 4oC.  
The pellet was washed with 75% ethanol, air dried, resuspended in 30 µL of TE buffer 
containing 20 µg/ml RNase A and incubated at 37oC for 15 min. 
 
2.2.3 Restriction digestion  
Plasmids were digested with the appropriate restriction enzymes for a minimum of 
4 h at 37oC.  The fragments were visualized on 1% (w/v) agarose gels (0.4 g agarose in 40 
mL of 1X TAE buffer, and 0.02% (w/v) ethidium bromide).  The samples were mixed 
with gel loading buffer (6x: 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol 
FF, and 40% (w/v) sucrose in water) and the gel was electrophoresed for 30 min at 130 V 
in the Miniature Horizontal Gel System MLB-06 (Tyler Research Instruments) with 1X 
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TAE buffer.  The gel was visualized and imaged using the Alphaimager Imaging System 
with AlphaEase software.   
 
2.3 Parasite cultures  
Human foreskin fibroblasts (HFF) and the laboratory strains, RH and RHΔHX, 
which are type I strains of T. gondii, were obtained from National Institutes of Health 
AIDS Research and Reference Reagent Program.  HFF cells were grown in Dulbecco's 
Modified Eagle Medium (DMEM) (Invitrogen) supplemented with 10% cosmic calf 
serum (Hyclone) and antibiotic-antimycotic (Invitrogen) and used for T. gondii infection.  
The infected HFF monolayers were maintained using Minimum Essential Medium 
(MEM) (Invitrogen) supplemented with 1% dialyzed calf serum (Hyclone) and antibiotic-
antimycotic.  The RHΔHX parasite strain was chosen because of the ability to generate 
transgenic parasites using hypoxanthine-xanthine-guanine phosphoribosyltransferase as a 
selectable marker (Donald et al., 1996).  Using a previously described method (Roos et 
al., 1994), transgenic parasites were generated by electroporation of RHΔHX with 
plasmids containing HXGPRT and selected and maintained in the culture media 
containing 25 µg/ml mycophenolic acid and 50 µg/ml xanthine.  RH parasites were 
electroporated with plasmids containing chloramphenicol acetyltransferase (CAT) as a 
selectable marker and maintained in media containing 20 µM chloramphenicol. Freshly 
released parasites were subcultured every few days until further needed.   
 
2.4 Transfection of Toxoplasma gondii by electroporation 
 Freshly lysed parasites were centrifuged at 1,500 rpm for 15 min and the pellet 
was resuspended in 400 µL electroporation buffer (120 mM KCl, 0.15 mM CaCl2, 10 mM 
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K2HPO4/KH2PO4 (pH 7.6), 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione).  
10 µg of plasmid DNA was added in 4 mm electroporation cuvettes and pulsed at a 
voltage of 1,500 V, resistance of 25 Ω, and a capacitance of 25 µF using the BTX model 
600 Electro Cell Manipulator (Genetronics).  The parasites were then added to a confluent 
plate of HFF cells after a 15 min incubation period, and grown for 24 h followed by 
addition of the appropriate selection.   
 
2.5 Isolation of genomic DNA 
 Genomic DNA was isolated using the DNAzol Reagent (Invitrogen) according to 
the manufacturer’s instructions.  Briefly, parasite pellets were resuspended in 500 µL of 
DNAzol Reagent and lysed by gentle pipetting, followed by centrifugation for 10 min at 
10,000 rpm at room temperature, and the viscous supernatant was transferred to a fresh 
tube.  The DNA was precipitated by the addition of 250 µL of 100% ethanol, mixing by 
inversion, and storing at room temperature for 3 min, followed by centrifugation at 4,000 
rpm for 2 min at room temperature to pellet the DNA.  The DNA precipitate was washed 
twice with 800 µL of 75% ethanol, air dried for 15 s, and resuspended in 200 µL of 8 mM 
NaOH and 32 µL of 0.1 M HEPES. 
 
2.6 Genotyping of Toxoplasma gondii 
 Isolated genomic DNA was subject to amplification by PCR using the primers 
specific to GRA6 and SAG2; GRA6-F1: TTTCCGAGCAGGTGACCT and GRA6-R1x: 
TCGCCGAAGAGTTGACATAG and SAG2.F2: ATTCTCATGCCTCCGCTTC and 
SAG2.R: AACGTTTCACGAAGGCACAC.  The PCR reaction consisted of 25 cycles of 
denaturing at 94oC for 15 s, annealing at 55oC for 15 s, and extension at 72oC for 45 s, 
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with a final extension at 72oC for 5 min.  PCR products were digested with MseI and 
HhaI for GRA6 and SAG2, respectively, and visualized on a polyacrylamide gel (4.8 mL 
30% acrylamide, 4.8 mL H20, 2.4 mL 5X tris-borate EDTA (TBE)), where TBE is 54 g/L 
Tris base, 27.5 g/L boric acid, 20 mL/L of 0.5 M EDTA, (pH 8.0).  
 
2.7 Lactate dehydrogenase enzymatic activity assay 
 Enzymatic assays were performed as previously described (Al-Anouti et al., 2004; 
Dando et al., 2001; Kavanagh et al., 2004).  Briefly, freshly released tachyzoites were 
harvested and lysed in 100 mM Tris (pH 7.4) and 0.5 mM PMSF protease inhibitor.  
Protein concentrations were determined using the Bradford reagent (BioRad Laboratories, 
Inc.).  Reactions were carried out at 25°C in a reaction buffer containing 100 mM Tris 
(pH 7.4), 0.1 mg/ml NADH (Sigma-Aldrich), and 5 µg of cell-free lysates.  Reactions 
were initiated by the addition of 1.6 mM pyruvate (Sigma-Aldrich) and monitored at 340 
nm for the change in absorbance of NADH (∈ = 6220 M-1cm-1).  The assays were 
performed in triplicate, and average values were presented with their standard deviations. 
 
2.8 Production of double stranded RNA 
 T7 promoter sites were incorporated into either side of the UPRT gene using the 
primers T7AntisenseUP:  TAATACGACTCACTATAGGGTTCCAAAGTACCGGT and 
T7promoterGG: TAATACGACTCATATAGG.  The PCR reaction consisted of 30 cycles 
of denaturing at 94oC for 30 s, annealing at 55oC for 30 s, and extension at 72oC for 2 min 
30 s, with a final extension at 72oC for 5 min.  The PCR template was then subjected to 
an in vitro transcription reaction (200 u of T7 polymerase, 2.5 mM rNTPs, 50 u Murine 
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RNase inhibitor, 10 mM DTT, 1/100 dilution pyrophosphatase) for 4 h at 37oC.  The 
reaction was quenched with 2 u RQ1 RNase-Free DNase (Promega Corp.) for 15 min at 
37oC.  The sample, visualized on a 1% agarose gel, was subjected to phenol:chloroform 
precipitation, and quantified by spectrophotometry (Genesys 10uv Thermo Electron 
Corporation) by measuring absorbance at 260 nm and 280 nm.    
 
2.9 RNA interference assay 
 Electroporation was used to introduce dsRNA corresponding to UPRT into 
parasites which were then infected onto HFF cells grown in a 24-well plate, and allowed 
to grow for 24 h.  The media was replaced with appropriate selection media, and 1 µCi of 
1H3 Uracil was added to each well.  HFF cells with only electroporation buffer and no 
parasites were used as a control.  After incubation at 37oC for another 4 h, the plate was 
chilled at -20oC for 2 min, followed by addition of 1 mL of 0.6 M trichloroacetic acid 
(TCA) to the existing media.  The monolayer was fixed for at least 1 h at 4oC.  The wells 
were washed repeatedly for approximately 4 h with ddH2O and gentle agitation.  
Scintillation counting was performed on each wash sample containing 250 µL of sample 
and 3 mL of scintillation fluid.  Once wash readings were approximately 50-300 cpm, the 
ddH2O was replaced with 0.5 mL of 0.1 N NaOH and incubated for 1 h at 37oC.  
Scintillation counting was performed on 250 µL of each sample with 3 mL of scintillation 
fluid. 
 
2.10 Antibodies 
The rabbit anti-red fluorescence protein (RFP) antibody was obtained from 
Biovision (Mountain View, CA).  The mouse anti-Myc antibody (9E10) and the mouse 
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anti-Tub (12G10) antibodies were developed by J. Michael Bishop, and Joseph Frankel 
and E. Marlo Nelsen, respectively, and obtained from the Developmental Studies 
Hybridoma Bank developed under the auspices of the NICHD and maintained by The 
University of Iowa (Iowa City, IA).  The rabbit anti-LDH1 and rabbit anti-LDH2 
antibodies were obtained from Dr. Stephen Parmley (Palo Alto Medical Foundation).  
The rabbit anti-RNaseIII antibody was produced using a peptide derived from the N-
terminal of the signature domain of an RNaseIII domain and obtained from ProSci 
Incorporated (Poway, CA).  The rabbit anti-Bag1 antibody was obtained from Dr. Louis 
Weiss.  Horseradish peroxidase-conjugated goat anti-mouse and horseradish peroxidase-
conjugated goat anti-rabbit were purchased from Rockland (Gilbertsville, PA).  
Rhodamine-conjugated sheep anti-mouse was purchased from Rockland (Gilbertsville, 
PA).  Finally, FITC-conjugated Dolichos biflorus agglutinin was obtained from Sigma-
Aldrich. 
 
2.11 Growth assays and immunofluorescence assays  
To monitor the tachyzoite growth, the parasites were infected onto HFF 
monolayers grown on coverslips and kept under 37°C and 5% CO2 for 24 and 48 hours 
(Al-Anouti et al., 2004).  To induce stage conversion and measure bradyzoite growth, the 
infected monolayers were grown under atmospheric CO2 and in RMPI-1640 media 
(Sigma-Aldrich) supplemented with 50 mM HEPES (pH 8.2), 5% dialyzed serum, and 
antibiotic-antimycotic for 5 days (Soete et al., 1993, Tomavo, 2001).  After 5 days, the 
alkaline stress was removed and parasites were grown under tachyzoite conditions for 
another 48 h to measure the interconversion ability.  
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Immunofluorescence assays were performed by fixing the infected monolayers 
grown on coverslips with 3% paraformaldehyde.  The nuclei of intracellular parasites and 
host cells were visualized by staining with 100 µM Hoechst (Sigma-Aldrich).  FITC-
conjugated Dolichos biflorus agglutinin (1:300) was used for the visualization of cyst 
structures.  The parasites, from an average of 100 vacuoles or cysts per coverslip, were 
counted in triplicate to determine the number of parasites per vacuole or cyst.   
For other immunofluorescence assays, the paraformaldehyde fixed monolayers 
were permeabilized with 0.25% Triton X-100 in PBS, and non-specific sites were blocked 
using 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS.  The slides were 
incubated with the primary antibodies: mouse anti-Myc (1:500), rabbit anti-TgLDH1 
(1:1,000) or rabbit anti-TgLDH2 (1:1,000).  Coverslips were then washed 3 times for 5 
min each in PBS and incubated with the secondary antibodies: rhodamine-conjugated 
sheep anti-mouse (1:800) or rhodamine-conjugated goat anti-rabbit (1:800).  All images 
were taken with a Q-imaging CCD camera on a Leica DMIRB microscope using the 
Northern Eclipse software. 
 
2.12 Immunodectection 
Western blot analyses were performed using the lysates prepared from freshly 
lysed parasites in 100 mM Tris-HCl (pH 7.6) containing 0.5 mM 
phenylmethylsulfonylfluoride (PMSF) protease inhibitor (Al-Anouti et al., 2004).  
Briefly, cell pellets were resuspended in PBS, sonicated, and centrifuged at 13,000 rpm 
for 15 min at 4oC.  The supernatant was separated from the cellular debris.  Protein 
concentration was measured using the Bradford reagent according to manufacturer’s 
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instructions.  Cell lysates were denatured in 5X SDS protein loading dye, resolved on a 
12% SDS-PAGE at 120 V for 1 h in a 1X SDS-PAGE running buffer (25 mM Tris-base 
(pH 8.3), 250 mM glycine, and 0.1% SDS) using the vertical gel electrophoresis system 
from BRL (Bethesday Research Laboratories), and transferred to a nitrocellulose 
membrane (Pall Corporation) at 80 V for 1.5 h in transfer buffer (20% methanol, 39 mM 
glycine, 48 mM Tris-base, 0.037% SDS, (pH 8.3)).  Following the transfer, blots were 
blocked in 5% non-fat milk in 1X Tris-buffered saline containing Tween®-20 (TBST; 
0.068 M NaCl, 8.3 mM Tris-base (pH 7.6), 0.1% Tween) for 1 h at room temperature.  
Membranes were then probed with the specific primary antibodies in 2% non-fat milk in 
TBST for 1 h at room temperature.  The primary antibodies used were: mouse anti-Myc 
(1:1,000), mouse anti-Tub (1:1,000), rabbit anti-LDH1 (1:2,000), rabbit anti-LDH2 
(1:2,000), rabbit anti-Bag1 (1:250), rabbit anti-RFP (1:250), and rabbit anti-RNaseIII 
(1:4,000).  The blots were washed 3 times for 5 min, incubated in the appropriate 
secondary antibody for 45 min at room temperature, and washed again 3 times for 5 min 
each.  The secondary antibodies used were: horseradish peroxidase-conjugated goat anti-
mouse (1:10,000) and horseradish peroxidase-conjugated goat anti-rabbit (1:20,000).  
Chemiluminescent detection was performed using the chemiluminescent HRP substrate 
kit (Millipore). 
 
2.13 Immunoprecipitation assays 
 In order to immunoprecipitate putative dicer proteins or TgAgo_ChFP, rabbit anti-
RNaseIII and rabbit anti-RFP were used, respectively.  Protein-A agarose beads (10 µL 
beads/500 µL reaction) were incubated with the primary antibody on a rotator for 1 h at 
room temperature.  The beads were collected by centrifugation at 4,000 rpm for 30 s and 
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the supernatant removed.  The appropriate parasites were lysed in either polysome lysis 
buffer (100 mM KCl, 5 mM MgCl2, 10 mM HEPES, 0.5% Nonidet P40, 1 mM DTT, 2 
mM vanadyl ribonuclease, 10 % SDS) for dicer immunoprecipitation, or a Tris buffer (50 
mM Tris-HCl, (pH 7.6), 1% Triton X-100, 150 mM NaCl, 0.1% SDS) for TgAgo_ChFP 
immunoprecipitation and incubated with the antibody bound beads for 4 h at 4oC while 
rotating.  The beads were washed 3 times for 5 min at 4oC with wash buffers, (100 mM 
KCl, 5 mM MgCl2, 10 mM HEPES, 0.5% Nonidet P40, 1 mM DTT, 2 mM vanadyl 
ribonuclease, 10 % SDS, 100 mM NaCl) and (50 mM Tris-HCl, (pH 7.6), 0.1% Triton X-
100, 150 mM NaCl, 0.1% SDS) for dicer and TgAgo_ChFP, respectively.  The bound 
proteins were eluted by addition of 30 µL SDS-loading dye and boiled for 5 min.  The 
samples were analyzed by western blot analysis and coomassie staining.   
 
2.14 Mass spectrometry  
 The sample was lysed, electrophoresed by SDS-PAGE, and immunoblotted onto a 
PVDF membrane as previously described.  The lane was cut into three sections and 
western blot analysis was performed on the two outer sections using rabbit anti-RFP 
(1:250) and horseradish peroxidase conjugated goat anti-rabbit (1:20,000).  The bands 
were visualized using 3 mg of the colorimetric substrate DAB (3,3'-diaminobenzidine) in 
20 mL of 0.05 M Tris-HCl (pH 7.2), and 20 µL of 3% H2O2, and matched to the unused 
section.  The band with the corresponding size was excised using a sterile blade in a 
laminar flow hood.  The band was washed 3 times each with methanol and ddH2O, and 
blocked with 1 mL of 0.5% polyvinylpyrrolidine-360 (Sigma) containing 100 mM acetic 
acid for 30 min at 37oC, followed by 5 washes with ddH2O.  Tryptic digestion was 
performed with 260 ng of sequencing grade trypsin (Promega Corp.) resuspended in 50 
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mM ammonium bicarbonate (pH 8.0) to a final concentration of 13ng/µL, at 37oC 
overnight with agitation.  The reaction was quenched by addition of formic acid at a final 
concentration of 1%.  Additional peptides were released by sonicating the membrane for 
3 min in 300 µL of ddH2O and the solution was concentrated to approximately 10 µL by 
speed vacuuming.  The tryptic peptides were analyzed by mass spectrometry using a 
matrix-assisted laser desorption ionization (MALDI)-time of flight (TOF) mass 
spectrometer (Applied BioSystems Voyager-DE™ PRO BioSpectrometry™ Workstation; 
Applied BioSystems, Framingham, MA).  The peptides were crystallized on a MALDI 
target plate (Applied BioSystems) using an α–cyano-4-hydroxycinnamic acid matrix 
(Sigma-Aldrich, Inc.) in 60% acetonitrile, 1% formic acid.  The tryptic peptide ion 
masses were compared to those generated by an in silico tryptic digestion of the 
TgAgo_ChFP protein using the MS-Digest program of Protein Prospector (UCSF; 
University of California, San Francisco, CA). 
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Chapter III 
Results 
 
This chapter is divided into two parts.  Part I focuses on the role of the lactate 
dehydrogenase enzyme of T. gondii in the process of interconversion.  Transgenic 
parasites were generated by over-expressing either TgLDH1 or TgLDH2 in tachyzoites 
and the phenotypes were monitored when the parasites were grown in the presence of 
alkaline stress.  Part II focuses on the argonaute protein of T. gondii, and its role in 
interconversion and post-transcriptional gene regulation.  The studies were aimed at 
determining the differentiation and gene knockdown abilities of a knockout strain of 
TgAgo and a transgenic strain over-expressing TgAgo. 
 
PART I: Physiological characterization of Toxoplasma gondii’s lactate 
dehydrogenases 
 
3.1 Genotyping of Toxoplasma gondii strains 
 When compared to type II strains of Toxoplasma gondii, type I strains have been 
shown to be a more virulent, lethal type of parasite, which show a minimal ability to 
differentiate into bradyzoites in vitro (Sibley and Boothroyd, 1992).  To ensure that the 
parental RH and RHΔHX strains used in these studies were type I strains, and were not 
contaminated with any type II strains, genotyping reactions were performed.  In order to 
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genotype the T. gondii strains as type I or type II, restriction fragment length 
polymorphisms (RFLP) of PCR amplified gene products were used.  The genes encoding 
SAG2 and GRA6 have been identified by Howe et al. (1997) and Fazaeli et al. (2000), 
respectively, to contain several polymorphisms that allow for genomic typing between the 
three types.  The oligonucleotide primers used for PCR amplification were designed by 
Khan et al. (2005).  200 bp of the 3’ terminus of SAG2 was amplified and digested with 
HhaI.  Type I does not contain the restriction site and therefore the product is the same 
size as the PCR fragment.  On the other hand, type II parasites contain the HhaI digestion 
site in the PCR amplified region, thus 2 fragments are produced from the digestion (Fig. 
3.1A).  The GRA6 gene was PCR amplified to produce a fragment of 346 bp, which was 
then digested with MseI.  Type I parasites contain the MseI site close to the 3’ end 
generating 2 fragments of 261 bp and 85 bp.  Type II parasites, on the other hand, contain 
the MseI site in the middle of the fragment generating 2 products of 162 bp and 182 bp 
(Fig. 3.1B).  Only patterns specific to type I were detected, thus confirming that the 
parental strains used were of type I origin and were not contaminated with any type II 
parasites. 
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Figure 3.1 Genotyping of two laboratory strains of Toxoplasma gondii, RH and 
RHΔHX.  (A) SAG2 and (B) GRA6 primers were used to generate PCR products which 
were then digested with HhaI and MseI, respectively.  The undigested and digested 
samples were resolved on a 12% polyacrylamide gel.  
 
 
 
 
 
 
47 
 
3.2 Over-expressing recombinant TgLDHs in Toxoplasma gondii 
To study the effect of TgLDH1 and TgLDH2 on differentiation, clonal parasites 
that stably over-expressed either TgLDH1 or TgLDH2 were generated.  Those selected 
for the study were named RML1-A & -B and RML2-A to -D, respectively where R 
indicates the RHΔHX parental strain, M indicates the Myc tag, and L1 and L2 indicate 
over-expressed TgLDH1 and TgLDH2, respectively. 
To determine levels of recombinant TgLDH1 and TgLDH2 expression in the 
tachyzoite stage, western blot analysis was employed.  Figure 3.2A indicated that 
tachyzoites of the parental parasite (RHΔHX) strain expressed detectable levels of 
TgLDH1, but not TgLDH2, which is in agreement with previous observations (Yang and 
Parmley, 1995, 1997).  Endogenous TgLDH1 has a molecular weight of ~35 kDa, and 
was detected in all samples prepared from the selected clones as well as in the RHΔHX 
strain, using an anti-TgLDH1 antibody.  In the RML1-A and RML1-B strains, 
recombinant TgLDH1 protein was detected by both anti-Myc and anti-TgLDH1 
antibodies, which resolved at ~39 kDa.  As expected, recombinant TgLDH2 (~40 kDa) 
was only detected in the four clonal RML2 (A to D) strains using anti-TgLDH2 and anti-
Myc antibodies, while no endogenous levels of TgLDH2 were detected in any of the 
strains, since tachyzoites do not express TgLDH2 (Fig. 3.2A). 
 To normalize the expression of the recombinant proteins in the transgenic clonal 
parasites, the expression levels, as detected by anti-TgLDH1 or anti-TgLDH2, were 
quantified against those of the internal control, tubulin (Fig. 3.2B).  Between the clonal 
TgLDH1 strains, RML1-A exhibited a higher level of recombinant TgLDH1 than RML1-
B.  Among the clonal TgLDH2 strains, RML2-C exhibited the lowest amount of 
recombinant TgLDH2 and RML2-A and RML2-D had the highest levels.  It was noted  
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Figure 3.2 Expression of the recombinant proteins in the selected clones.  
(A)Western blot analyses of recombinant Toxoplasma gondii lactate dehydrogenase 
(TgLDH1 and TgLDH2) expression. Anti-Myc, -TgLDH1, -TgLDH2 and -Tub 
antibodies were used in revealing the corresponding proteins as indicated on the left. 
Estimated sizes of the detected bands are indicated on the right. (B) Comparative levels of 
the recombinant TgLDH proteins among the clonal strains was obtained following 
densitometric measurements of the band intensities and normalized against those of 
tubulin (Tub). 
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that there was no direct relationship between the level of recombinant protein expression 
and the endogenous level of TgLDH1 expression. 
Prior to phenotypical analyses, immunofluorescence assays were performed to 
ensure that recombinant TgLDH1 and TgLDH2 proteins were expressed uniformly in 
each clone (Fig. 3.3).  The expression of recombinant proteins was uniform in all strains 
as detected by an anti-Myc primary antibody and a rhodamine-conjugated anti-mouse 
secondary antibody.  Figure 3.3 shows the recombinant protein in the RML1-B strain.  
The results were similar for all other clones.  It was observed that recombinant TgLDH1 
and TgLDH2 proteins localized to the cytosol, which is in agreement with previous 
studies (Ferguson et al., 2002).  
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Figure  3.3 Expression of TgLDH1 in tachyzoites.  Immunofluorescence detection 
of Myc-tagged Toxoplasma gondii lactate dehydrogenase 1 (TgLDH1) in the tachyzoites 
of RML1-B.  Nuclei of the HFF host and the tachyzoites were stained with Hoechst, as 
indicated by an arrowhead and an arrow, respectively.  The scale represents 20 microns.   
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3.3 Effect of TgLDH1 or TgLDH2 over-expression on overall enzymatic activity 
of TgLDH 
To determine if the varied levels of over-expression altered the overall activity of 
TgLDH, an LDH enzymatic assay was performed by measuring the change in NADH 
absorbance at 340 nm when pyruvate was added to freshly lysed parasites (Table 3.1).  
The overall TgLDH activity of the parental tachyzoites, RHΔHX, was found to be 1473 ± 
4 nmol. min-1.mg-1.  The over-expression of TgLDH1 in the RML1-A and RML1-B 
strains displayed similar activity as parental, 1428 ± 107 and 1933 ± 241 nmol. min-1.mg-
1, respectively.  The RML2-A, RML2-B, RML2-C, and RML2-D strains with over-
expressed TgLDH2, with activities of 1260 ± 287, 1072 ± 210, 1009 ± 185, and 1167 ± 
132 nmol. min-1.mg-1, respectively, also resembled the activity of the parental strain.  
Therefore, varied levels of over-expression did not decrease nor increase the overall 
enzymatic activity of TgLDH.   
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Table 3.1  Overall enzymatic activity of TgLDH in transgenic and parental 
strains.  Enzymatic activity of parental and transgenic clones was monitored by the 
change in absorbance of NADH at 340 nm.  The values and standard deviations are given 
in nmol.min-1.mg-1. 
 
 
 
 
 
Strains Activities  (nmol.min-1.mg-1) 
RHΔHX 1473 ± 4 
RML1-A 1428 ± 107 
RML1-B 1933 ± 241 
RML2-A 1260 ± 287 
RML2-B 1072 ± 210 
RML2-C 1009 ± 185 
RML2-D 1167 ± 132 
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3.4 Phenotypical analyses of transgenic parasites over-expressing TgLDH1 and 
TgLDH2  
Clonal RML1-B, RML2-A, and RML2-D strains were selected for further 
phenotypical analyses since there was no apparent correlation between the levels of over-
expression, localization and the overall TgLDH activity.   
 3.4.1 Growth of transgenic parasites under tachyzoite conditions 
Growth of tachyzoites was monitored to determine if over-expression of TgLDH 
caused any changes to occur.  Growth assays were conducted using clonal parasites from 
early and late passages, where the former were from less than three passages and the latter 
from six passages, to ensure that the results were consistent, since it has previously been 
reported that serial passages of transgenic T. gondii cultures may cause a reduction in the 
expression of recombinant proteins (Van et al., 2007).   
The parasites were infected under tachyzoite conditions, and the number of 
parasites in the vacuoles was monitored from the early (Fig. 3.4 A and B) and late 
passages (Fig. 3.4 C and D) after 24 and 48 hours.  The infected monolayers were fixed 
after 24 or 48 hours and stained with Hoechst to facilitate counting.  At 24 hours post-
infection, 50% of vacuoles formed by all strains, including RML1-B, RML2-A, RML2-D, 
and RHΔHX, contained 8 parasites.  At 48 hours post-infection, all strains showed a 
similar growth pattern of having about 50% of vacuoles with more than 32 parasites, and 
the early and late passages exhibited the same trend.  Therefore, the over-expression of 
recombinant TgLDH1 or TgLDH2 proteins had minimal effect on the growth of 
tachyzoites, as compared to the parental strain, under tested conditions.   
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Figure 3.4 Tachyzoites’ growth analyses.  Comparative growth analysis of parasites 
from an early passage (A and B) and late passage (C and D) is displayed as the fraction 
(%) of vacuoles containing 2, 4, 8, 16, or >32 parasites.  An average of 100 vacuoles were 
counted from each strain at 24 (A and C) or 48 (B and D) hours post-infection, in 
triplicate. 
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3.4.2 Differentiation of transgenic parasites using alkaline media 
 The expression of TgLDH1 and TgLDH2 proteins has been widely used as a 
marker of parasite differentiation (Weiss and Kim, 2000; Yang and Parmley, 1997), and 
previous studies have shown that knockdown of TgLDHs caused a decrease in 
differentiation ability (Al-Anouti et al., 2004).  Thus, it was important to investigate 
whether TgLDH1 or TgLDH2 over-expression also affected the parasite’s ability to 
differentiate into bradyzoites.   
Parasites were infected onto HFF cells, and the monolayers were cultured under 
alkaline conditions (pH 8.2) for 5 days, which has been shown to cause differentiation 
(Boothroyd et al., 1997; Soete et al., 1993).  To ensure that the cyst structure formation 
correlated with the presence of bradyzoite markers, western blot analysis was performed.  
Parasites cultured under alkaline conditions were compared to those cultured under 
tachyzoite conditions for the presence of the bradyzoite-specific antigen 1 (BAG1, 30 
kDa) using the anti-BAG1 antibody (Fig. 3.5; Bohne et al., 1995).  A mixed population 
strain of TgLDH2 over-expressed parasites, RML2-mix, was used as a test in western blot 
analysis, while PLKΔHX, a type II parasite known to readily differentiate, was used as a 
positive control.  Figure 3.5 shows that BAG1 is detected in the lysate of the bradyzoite 
strains of both RML2-mix and PLKΔHX, while it is not detected in the lysate of the 
tachyzoite samples, further confirming that differentiation did occur and can be correlated 
with cyst wall formation that appears in parasites cultured for 5 days in alkaline media.   
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Figure 3.5 Expression of the bradyzoite marker BAG1.  Western blot analysis of 
Toxoplasma gondii tachyzoites (tz) and bradyzoites (bz) of a type II strain, PLKHX, and a 
transgenic line over-expressing TgLDH2, RML2-mix.  Anti-BAG1 was used to reveal the 
BAG1 protein at 30 kDa in the bradyzoite samples only.  Tubulin was used as a loading 
control. 
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To determine if cyst formation occurred in the transgenic clones, levels of 
recombinant proteins in the clonal parasites were evaluated using an anti-Myc primary 
antibody and a rhodamine-conjugated sheep anti-mouse secondary antibody; while cyst 
wall formation was detected using FITC-conjugated Dolichos lectin.  Figure 3.6 indicates 
that a detectable cyst wall was observed in the RML2-A strain, which was similar to all 
other transgenic strains, and that recombinant protein expression correlated with the cyst 
wall.  The formation of cysts was counted in all strains and quantified against the total 
number of vacuoles.  It was observed that the parental RHΔHX strain could differentiate, 
with ~14% of vacuoles forming cyst structures under conditions tested.  Notably, all 
clonal strains, including RML1-B, RML2A and RML2-D, showed an enhanced ability to 
differentiate and form cyst structures.  From all transgenic parasite clones counted, over 
half of the vacuoles exhibited distinctive cyst structures, demonstrating that TgLDH over-
expression caused an increase from ~14% (parental) to ~60% (transgenic) in cyst 
formation (Fig. 3.7).  To ensure that differentiation and cyst formation was not an artifact 
derived from the expression of a recombinant protein, an unrelated protein, Myc-tagged 
GFP, was over-expressed and differentiation was monitored.  It was observed that the 
GFP over-expression resulted in ~12% of cyst formation, which was similar to the 
parental strain, suggesting that differentiation was not enhanced by an unrelated protein.  
This finding confirmed that the increase in differentiation was directly correlated to 
TgLDH over-expression.   
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Figure 3.6  Differentiation of parasites over-expressing TgLDH by alkaline stress.  
Immunofluorescence image shows the cyst structure of the RML2-A strain which was 
similar to all other transgenic parasites.  The nuclei were stained with Hoechst.  The 
arrowhead indicates the nucleus of the HFF host cell, while the arrow indicates the nuclei 
of the bradyzoites.  The recombinant Myc-tagged TgLDH2 was revealed by an anti-Myc 
primary antibody and a rhodamine-conjugated sheep anti-mouse secondary antibody.  
The cyst structure was revealed using FITC-conjugated Dolichos lectin staining.  The 
scale represents 15 microns.   
 
 
 
 
 
 
 
60 
 
 
 
 
 
Figure 3.7 Quantification of cyst formation in transgenic and parental parasites.  
Quantitative analyses of cyst formation were conducted in the differentiated RML1-B, 
RML2-D, RML2-A, and RHΔHX strains.  The fraction (%) of vacuoles that formed cysts 
was calculated from at least 100 vacuoles and from three independent assays.  
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3.4.3 Growth of transgenic parasites under alkaline conditions 
To evaluate parasite growth under alkaline conditions, the number of parasites in 
each vacuole, after 5 days of culturing in alkaline media (pH 8.2), was counted.  Figure 
3.8 shows that the parental RHΔHX strain retained a sufficient ability to multiply under 
alkaline conditions and formed 2, 4, 8, and 16 parasites per vacuole at 5 days post-
infection.  The distribution of these vacuoles was almost equal (20-30%).  In the clonal 
RML1-B and RML2-D strains, the majority (~50-60%) of the vacuoles contained 2 
parasites, suggesting that alkaline conditions halted parasite multiplication at an early 
division stage.  On the other hand, the RML2-A strain exhibited a unique growth pattern 
blending the characteristic of the parental parasites in having an even distribution of the 
number of vacuoles containing either 2, 4, and 8 parasites per vacuole, but not 16 
parasites per vacuole, while having 50-60% differentiated vacuoles.   
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Figure 3.8 Growth analyses of Toxoplasma gondii under alkaline conditions.  
Comparative growth analyses of parasites that were cultured under alkaline conditions for 
5 days is displayed as the fraction (%) of vacuoles containing 2, 4 8, 16, or >32 parasites.  
An average of 100 vacuoles was counted for all strains in triplicate.  
 
 
 
 
 
 
 
63 
 
3.4.4 Cyst formation of transgenic parasites under tachyzoite conditions  
To determine if over-expressing TgLDH1 or TgLDH2 could enhance 
differentiation of T. gondii in the absence of a stress, the parasites were grown under 
tachyzoite conditions and stained with Dolichos-FITC to measure cyst formation.  It was 
observed that no cyst structures were formed in all strains, indicating that TgLDH did not 
enhance cyst formation under tachyzoite conditions (data not shown).   
3.4.5 Cyst formation of transgenic parasites after the removal of stress 
It was further determined whether the over-expression of TgLDH1 or TgLDH2 
altered the bradyzoite’s ability to reconvert into tachyzoites after the alkaline stress was 
removed.  Parasites from all clonal strains, along with the parental, RHΔHX, were grown 
under alkaline media, as previously described.  After 5 days, the parasites were returned 
to tachyzoite conditions and grown for 48 hours.  The parasites were fixed, and stained 
with Dolichos-FITC for visualization of cysts at both time points.  It was determined that 
both parental and transgenic clones could successfully reconvert into tachyzoites after 48 
hours.  After 5 days in alkaline media, RHΔHX formed 18.3 ± 4.2% cysts.  When 
reintroduced back into tachyzoite conditions for 48 hours, a total of 7.2 ± 0.2% of 
vacuoles remained encysted, indicating that some vacuoles were unable to revert into 
tachyzoites.  On the other hand, after 5 days in alkaline media, transgenic clones formed 
an average of 49.6 ± 3.8% cysts.  After being reintroduced back into tachyzoite 
conditions for 48 hours, 8.5 ± 0.3% of vacuoles remained encysted (Fig. 3.9).  Therefore, 
although TgLDH1 or TgLDH2 over-expression may play a role in enhancing the 
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differentiation process under stressful conditions, it does not cause the parasites to remain 
encysted after the stress is removed.   
Overall, all clonal parasites expressing either of the recombinant TgLDH proteins 
could easily differentiate and slowly multiply in comparison to the parental parasite under 
alkaline conditions.  Also, the majority of the bradyzoites were able to reconvert into 
tachyzoites once the stress was removed.  These findings suggest that TgLDH plays an 
important role in the differentiation process of Toxoplasma gondii.  
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Figure 3.9 Cyst formation after removal of stress.  Quantification of cysts after 
culturing in alkaline media for 5 days, and returning the parasites to tachyzoite conditions 
for 48 h.  An average of 100 vacuoles was counted in triplicate.  The average values for 
RML1-B, RML2A and RML2-D are shown as transgenic clones.    
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PART II: The role of argonaute in Toxoplasma gondii  
3.5 Over-expression of T. gondii argonaute fused to a cherry fluorescent protein  
To investigate the physiological function of TgAgo, four strains of parasites were 
used: (i) the parental RH and RHΔHX strains, (ii) a previously characterized TgAgo null 
mutant (obtained from Dr. Boothroyd, Stanford University School of Medicine), and (iii) 
a transgenic line constitutively over-expressing a TgAgo_ChFP fusion.   
To detect the presence and level of TgAgo_ChFP in T. gondii, western blot 
analysis was used.  Since cherry fluorescent protein is a derivative of the red fluorescent 
protein (RFP), the antibody against RFP was used to detect the fusion.  The molecular 
weight of TgAgo is ~58.5 kDa, while that of ChFP is ~27 kDa, generating a fusion 
product of ~85.5 kDa, which was detected on the blot.  The lysate of the parental RH 
parasite was used as a negative control, while a GFP_ChFP fusion protein was used as a 
positive control and was detected at ~54 kDa (Fig. 3.10).  A band at ~85 kDa was 
revealed only in the TgAgo_ChFP parasites, but a band at ~27 kDa was also seen 
indicating that degradation or cleavage of ChFP had occurred.       
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Figure 3.10 Expression of TgAgo_ChFP in transgenic parasites. Western blot 
analysis was used to detect the TgAgo_ChFP fusion protein revealed by an anti-RFP 
antibody.  RH parasites were used as a negative control, while GFP_ChFP was used as a 
positive control.  The estimated sizes are indicated on the right.   
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Following identification of the fusion protein by western blot analysis, 
fluorescence microscopy was used to verify that the fusion protein was producing cherry 
fluorescence and that the localization of the fusion was similar to argonaute proteins in 
other organisms.  Upon monitoring cherry fluorescence, it was observed that the protein 
localized mainly to the cytosol when compared to Hoechst staining of the nuclei, which is 
in agreement with previous studies (Fig. 3.11; Sen and Blau, 2005).     
Furthermore, mass spectrometry was utilized to unambiguously identify the fusion 
protein.  The lysate containing the fusion protein was electrophoresed and electroblotted 
onto a PVDF membrane and the band was identified by a colorimetric substrate of 
horseradish peroxidase (HRP).  The band was excised, digested with trypsin, and 
analyzed by mass spectrometry (data not shown).  The identification of the peptides was 
not clear since many of the peptides were the same size as autolysis peaks of trypsin.  
There were a few bands that seemed promising; however the amount of protein present 
was limited so the protein identification was not sufficient to fully confirm the fusion. 
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Figure 3.11 Expression and localization of TgAgo_ChFP in tachyzoites.  
Fluorescent microscopy was used to detect  TgAgo_ChFP in the tachyzoite parasites.  
The nuclei of the parasites were stained with Hoechst.  The scale represents 10 microns. 
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3.6 Interconversion ability of Toxoplasma gondii strains with altered TgAgo 
expression  
 Database mining for TgAgo revealed that the expression of TgAgo in type I 
parasites is elevated as compared to type II based on mRNA expression profiles (Fig. 
3.12).  This observation led to the hypothesis that argonaute may play a role as a negative 
regulator in the differentiation process since type I parasites differentiate less than type II.  
That is, higher levels of argonaute may decrease the ability of the parasite to differentiate 
into bradyzoites.  This hypothesis was tested by comparing the differentiation ability of 
transgenic parasites containing TgAgo_ChFP with the knockout (AgoKO) strain and 
parental parasites under alkaline conditions.   
Immunofluorescence assays were used to monitor cyst formation in all the strains, 
where the cyst wall was detected by the FITC-conjugated Dolichos lectin.  Many cyst 
structures were detected in both the over-expressed TgAgo_ChFP clonal strain and the 
AgoKO strain when compared to a parental, RHΔHX, strain (Fig. 3.13).  Cyst formation 
was quantified by counting the number of vacuoles that formed cysts under tested 
conditions in all three strains (Fig. 3.14).  The parental strain formed ~14% of cysts, 
whereas the AgoKO strain formed ~70% of cysts, and the transgenic clone formed ~40% 
of cysts.  Therefore, TgAgo may play a role in the interconversion process, but the 
definition of that role is still unknown.       
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Figure 3.12 Expression profile of TgAgo.  The mRNA levels of TgAgo were 
determined by microarray analyses in all three types of parasites.  This data was provided 
to ToxoDB pre-publication by Paul Davis and David Roos (http://toxodb.org; Oct. 2008).  
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Figure 3.13 Differentiation of parasites with altered TgAgo levels.  Parasites were 
cultured for 5 days under alkaline conditions and subjected to immunofluorescence 
assays.  Cysts are revealed by Dolichos-FITC, nuclei are revealed using Hoechst staining, 
and TgAgo_ChFP was identified by the cherry fluorescence.  The scale represents 20 
microns.   
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Figure 3.14 Quantification of cyst formation in strains with altered TgAgo levels.  
Quantitative analyses of cyst formation were conducted for the differentiated 
TgAgo_ChFP, AgoKO, and RHΔHX. The fraction (%) of vacuoles that formed cysts was 
calculated from at least 100 vacuoles and from three independent assays. 
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3.7 The role of TgAgo in an RNA interference-like pathway 
 The discovery of an argonaute gene in T. gondii has suggested that an RNAi-like 
pathway exists in the parasite, and early experiments have shown that gene knockdown is 
observed upon introduction of double stranded RNA specific to the UPRT and HXGPRT 
genes (Al-Anouti et al., 2004).  To determine if argonaute plays a specific role in this 
knockdown phenomenon, the following studies aimed to monitor any changes in gene 
knockdown ability when argonaute is either over-expressed or knocked out relative to a 
parental control.     
3.7.1  Measuring RNAi activity in RH parental parasites 
To determine the maximum knockdown that could be observed in T. gondii, RH 
parental parasites were used as a positive control.  UPRT dsRNA was generated and 
increasing amounts were electroporated into parasites that were infected onto HFF 
monolayers.  After 24 hours, radioactive uracil was added to the media, parasites were 
grown for another 4 hours, and the amount of incorporated radioactivity was measured.  If 
knockdown of UPRT was successful, then the parasites would lose the ability to 
incorporate radioactive uracil.  As a control, the ability of parasites to incorporate uracil 
was measured in parasites that were electroporated with 0 μg of dsRNA and the resulting 
level of radioactivity was set as 100%.  Figure 3.15 shows that the introduction of ~22 µg 
of RNA by electroporation resulted in a maximum knockdown of ~60%.  Any increase in 
RNA concentration greater than 22 µg caused a plateau effect.   
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Figure 3.15 RNA interference assay of RH parental parasites with a range of 
dsRNA concentrations.  Knockdown of UPRT was measured using radioactively 
labelled uracil.  Increasing amounts of UPRT dsRNA was electroporated into RH 
parasites and the percentage of knockdown is shown as compared to control with 0 μg 
dsRNA.  The experiment was repeated in triplicate and the values are given with their 
standard deviations.   
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3.7.2 Measuring RNAi activity in parasites containing altered levels of 
TgAgo  
 To determine if TgAgo plays a role in the gene knockdown phenomenon observed 
in T. gondii, the UPRT dsRNA was electroporated into both the AgoKO and 
TgAgo_ChFP transgenic parasite lines, and the knockdown was measured using 
radioactive uracil as previously described.  As expected, the AgoKO line showed no 
ability to cause knockdown of UPRT (Fig. 3.16A).  The amount of uracil that was 
incorporated was similar to the control parasites that did not contain dsRNA.  
Unexpectedly, the TgAgo_ChFP transgenic line also showed an inability to cause gene 
knockdown of UPRT (Fig 3.16B).  Similar to the AgoKO strain, the TgAgo_ChFP strain 
had values close to control with increasing dsRNA concentrations.      
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Figure 3.16 RNAi activity of parasites with altered levels of TgAgo.  Double 
stranded UPRT was electroporated into (A) AgoKO and (B) TgAgo_ChFP, and an RNAi 
assay was performed using radioactively labelled UPRT.  The percentage of knockdown 
as compared to control is shown relative to the amount of UPRT dsRNA electroporated.  
The experiment was repeated in triplicate and the values are given with their standard 
deviations. 
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3.8 The effect of altered TgAgo expression on levels of putative dicer proteins  
In order to study if the alteration of TgAgo expression affected the levels of 
putative dicer proteins, western blot analysis was conducted.  Putative dicer proteins were 
revealed using an antibody created against a conserved peptide sequence of the RNaseIII 
domain of dicer (rabbit anti-RNaseIII).  Figure 3.17A shows 3 reactive bands when 
probed with anti-RNaseIII at ~120, ~70, and ~40 kDa.  RH parasites were used as a 
control for natural protein levels.  The levels of the 3 bands were quantified against those 
of tubulin (Fig. 3.17B).  When over-expressing TgAgo_ChFP, there is a slight increase of 
the ~120 kDa band from levels in RH, but a drastic decrease in the AgoKO strain.  When 
comparing the ~70 kDa band, the levels in RH are higher than in the other two strains, 
with AgoKO having the lowest levels.  Alternatively, when comparing the ~40 kDa band, 
the levels in RH are the lowest of the three strains, with AgoKO having the highest levels.  
These results suggest that putative dicer proteins may be up-regulated or down-regulated 
depending on expression of TgAgo.  
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Figure 3.17 Expression of RNaseIII containing proteins in strains with altered 
TgAgo levels.  (A) Western blot analysis of RH, TgAgo_ChFP, and AgoKO strains with 
anti-RNaseIII antibody.  Tubulin was used as a loading control, and approximate sizes are 
indicated on the right.  (B) Quantitative analysis of putative dicer proteins as compared to 
tubulin was obtained by densitometry for all three strains.   
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To identify the putative dicer bands, immunoprecipitation (IP) reactions were 
performed using anti-RNaseIII bound to protein-A agarose beads.  The process consisted 
of a pre-clearing step to remove non-specific proteins that bind to the protein-A agarose.  
Figure 3.18 shows the coomassie stain of the pre-clear and IP samples.  Many bands were 
observed in the pre-clear sample, while only the heavy chain of the antibody was 
observed in the IP sample.  After western blot analysis using anti-RNaseIII (Fig. 3.18), 
two bands were revealed at ~40 and ~120 kDa in both the pre-immune sample and RH 
lysate that was used as a positive control.  In the IP sample, a thick band was observed at 
~55 kDa that was specific to the heavy-chain of the antibody, but no bands specific to 
anti-RNaseIII were observed.  This suggests that the protein was bound to the beads, and 
removed in the wash steps.  Therefore, the ability to pull-down and identify putative dicer 
proteins was not successful.  Thus, further optimization of the experiment is necessary to 
successfully characterize the putative dicer proteins.    
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Figure 3.18 Identification of putative dicer proteins by immunoprecipitation.  
Immunoprecipitation was used to pull-down putative dicer proteins by the anti-RNaseIII 
antibody bound to protein-A agarose beads.  (A) A coomassie stain shows many bands in 
the pre-clear sample, while only the heavy-chain of the antibody is seen in the IP sample.   
(B) Western blot analysis with anti-RNaseIII indicates that putative dicer proteins were 
observed in the pre-clear sample that were similar to the RH lysate sample, however no 
bands were pulled down in the IP sample.  Approximate sizes are indicated on the right. 
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Chapter IV 
Discussion and Future Work 
 Toxoplasma gondii is a widespread pathogen that infects approximately one-third 
of the world’s population.  Typically asymptomatic in healthy individuals, T. gondii can 
remain dormant for the lifespan of the host as encysted bradyzoites.  However, if the host 
becomes immuno-compromised due to illness such as AIDS, T. gondii can reconvert from 
its dormant stage into the highly virulent tachzyoite stage and cause a recurrence of 
infection that may prove fatal (Ferguson et al., 2002; Lindsay et al., 1991; Luft and 
Remington, 1992).  The interconversion between bradyzoites and tachzyoites is thought 
to be an important process in the pathogenesis of the parasite; however studies of the 
process have proven unsuccessful in determining the mechanisms behind interconversion 
and thus remains poorly understood (Reiter-Owona et al., 2000).  The current studies 
have focused on lactate dehydrogenase and argonaute, and the roles they may play in this 
process.  Elucidation of the mechanism of interconversion may eventually lead to 
development of possible drug targets that would prevent the parasite from entering a 
dormant stage, thus preventing chronic toxoplasmosis.  
Previous studies on T. gondii lactate dehydrogenase indicated that knockdown of 
TgLDH resulted in variable growth rates under both tachyzoite and bradyzoite conditions.  
More importantly, the differentiation ability was impaired in vitro and the parasites were 
unable to form tissue cysts in a murine model system.  The parasites in the mice were not 
as virulent, and the mice survived a challenge with parental parasites that would typically 
83 
 
cause 100% mortality.  These results suggested that TgLDH is important for both the cell 
cycle and differentiation ability of T. gondii (Al-Anouti et al., 2004).  Therefore, it was of 
interest to study the effect of over-expressing TgLDH in tachyzoites, and measuring the 
resulting phenotypes in relation to growth and differentiation ability.   
Furthermore, it was also of interest to study the role of the argonaute protein in a 
putative gene knockdown pathway.  In other organisms, posttranscriptional gene 
silencing, known as RNA interference, has offered insight into the importance of the 
pathway, as well as provided a genetic tool for studying the organism.  The identification 
of T. gondii argonaute, and the knockdown phenomenon generated by introduction of 
dsRNA leads to speculations that an RNAi-like pathway exists in T. gondii (Al Riyahi et 
al., 2006).  Thus, current studies aimed to measure the effect of differentially expressing 
TgAgo on the knockdown phenomenon, to better understand the phenomenon within the 
parasite.  Moreover, argonaute proteins have been identified as key players in other 
cellular functions in many organisms (Carmell et al., 2002; Jaronczyk et al., 2005).  
Therefore, the studies also revolved around the parasites ability to successfully 
differentiate in vitro upon the over-expression or knockout of TgAgo.           
 
4.1 Validation of parental parasites as type I parasites  
In order to further characterize the role of TgLDH’s in T.gondii, transgenic lines 
over-expressing Myc-tagged TgLDH1 and Myc-tagged TgLDH2 were generated.  The 
parental parasites, RH and RHΔHX, used for generation were first subjected to 
genotyping studies to ensure that there was no contamination with any type II parasites 
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that may have occurred during routine culture.  This was important because the present 
studies involved the formation and quantification of bradyzoites in vitro, and since type II 
parasites have an increased ability to differentiate, any contamination would have skewed 
the results (Sibley and Boothroyd, 1992).   
 Single nucleotide polymorphisms (SNPs) are DNA sequence variations where one 
basepair in the genomic sequence is altered between different strains or types of an 
organism.  These SNPs allow for genotyping studies that involve restriction fragment 
length polymorphisms.  In this case, sequences of the genome that contain SNPs are 
amplified by PCR, and further digested using restriction endonucleases.  Since one type 
of the parasite will contain the correct restriction site, digestion will occur.  However, the 
presence of an SNP in another type of parasite will eliminate the restriction site thus 
preventing digestion.  This results in varying digestion patterns in differing types of 
parasites.  Two genes, GRA6 and SAG2, have been shown to contain SNPs, and were 
thus used in these studies to validate the typing of the parasite (Fig. 3.1).  The resulting 
banding patterns were compared with those identified for type I and type II parasites and 
it was concluded that only type I parasites were present (Khan et al., 2005).  Since 
differentiation studies revealed a relatively high number of cyst structures in parental 
parasites when using alkaline media, as compared to the low values found in literature 
(Radke et al., 2006), it suggests that these parasites have type II characteristics.  
However, since genotyping confirmed the parasites as type I, the high values were 
possibly due to the method of quantification.  Since the same method of quantification 
was used for all experimental strains, the values were comparable to each other.   
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4.2 Transgenic parasites over-expressing TgLDHs were successfully generated  
T. gondii lactate dehydrogenase (TgLDH) is an important enzyme in the 
glycolysis pathway that catalyzes the interconversion of pyruvate to lactate.  After an 
immune response, the parasites differentiate into bradyzoites, which are the slowly 
multiplying, encysted form that primarily utilize glycolysis for energy production.  To 
study the importance of TgLDH’s on bradyzoite formation, transgenic parasites over-
expressing either TgLDH1 or TgLDH2 were used.  The clonal parasites were analysed by 
western blot analysis for the presence of TgLDH (Fig. 3.2A).  The clonal parasites 
expressed either TgLDH1 (~39 kDa) or TgLDH2 (~40 kDa) whose larger sizes 
corresponded to addition of the Myc-tag.  The light bands found in the anti-LDH2 panel 
were the residual signals resulting from successive anti-Myc and anti-LDH2 antibody 
incubations. The blot was first revealed using an anti-Myc antibody and then stripped 
prior to anti-LDH2 incubation (Fig. 3.2A). 
The levels of over-expressed TgLDHs in all clones were quantified against those 
of tubulin (Fig. 3.2B).  Between the clonal TgLDH1 strains, RML1-A exhibited a higher 
level of recombinant TgLDH1 than RML1-B.  Among the clonal TgLDH2 strains, 
RML2-C exhibited the lowest amount of recombinant TgLDH2 and RML2-A and RML2-
D had the highest levels.  It was noted that there was no direct relationship between the 
level of recombinant protein expression and the endogenous level of TgLDH1 expression.  
That is, varying amounts of over-expressed protein was observed that did not depend on 
or relate to endogenous levels of TgLDH1.  The varied levels of recombinant TgLDH1 
and TgLDH2 expression in the clonal strains might be the result of the integration 
frequency and location where the random gene integration took place, which is quite 
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common in T. gondii (Donald et al., 1996; Striepen et al., 1998).  If there was a higher 
frequency of integration in one clone versus another, the levels of over-expression would 
have increased regardless of endogenous levels of TgLDH1.  It is also important to note 
that if random integration had occurred within a genomic sequence coding for a specific 
gene, the phenotypes observed may result from the loss of a different gene.  However, 
this is unlikely since the possibility of the integration interrupting the same gene in each 
clone is improbable, and so the same phenotype that was observed in multiple clones is 
likely due to TgLDH over-expression.  It was also noted that no endogenous levels of 
TgLDH2 appeared when probed with anti-LDH2, thus ensuring that the parasites were in 
fact in the tachzyoite stage and not in the bradyzoite stage.  Furthermore, the level and 
localization of the over-expressed proteins in tachyzoites was detected by 
immunofluorescence assays (Fig. 3.3).  Only clone RML1-B is shown, however all other 
clones exhibited the same result.  The over-expressed proteins were revealed using 
rhodamine-conjugated mouse anti-Myc so that the over-expressed proteins, in particular 
TgLDH1, could be identified apart from endogenous TgLDH1.  It was observed that the 
over-expressed proteins could successfully be revealed with anti-Myc and that the 
localization was in the cytosol, which is in agreement with previous studies (Ferguson et 
al., 2002).       
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4.3 TgLDH over-expression did not alter the overall TgLDH enzymatic activity 
or growth of parasites under tachyzoite conditions 
Due to the distinctive over-expression, it was expected that a change in the overall 
TgLDH enzymatic activity would occur.  The enzymatic activity was determined by 
measuring the absorbance of NADH after addition of pyruvate to lysates which were 
compared to parental and host cell controls.  Unexpectedly, neither an increase nor 
decrease in overall TgLDH activity was detected (Table 3.1).  It has been suggested that 
the active TgLDH enzyme is formed upon the assembly of a homotetrameric complex 
(Dando et al., 2001).  If the recombinant proteins were non-functional, due to mis-folding 
or mutations, the proteins would have interfered with the assembly of wild-type TgLDH 
complexes and would have decreased the overall TgLDH activity.  It is also likely that the 
mis-folded proteins would have been degraded and given rise to truncated and unstable 
forms of the recombinant proteins.  If this was the case, multiple bands with varying 
molecular weights would have been detected during western blot analyses.  However, 
only single bands were detected when either the anti-Myc or anti-TgLDH antibodies were 
used (Fig. 3.2A) suggesting that stable proteins were present.  On the other hand, if the 
recombinant proteins were functional and able to form ternary complexes, an increase in 
the overall enzymatic activity would have been observed.  However, since an increase 
was not observed, it is possible that the recombinant proteins were sequestered upon over-
expression and thus were unable to participate in formation of homotetrameric 
complexes.  This sequestering phenomenon has been observed in many organisms upon 
over-expression of proteins, in particular, the formation of inclusion bodies in bacteria is 
quite common and leads to inactive proteins (Kiefhaber et al., 1991; Mukhopadhyay, 
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1997).  If sequestered, the recombinant proteins would have been protected from 
degradation as well as from the formation of active ternary complexes, while still 
remaining in the cytosol (Fig. 3.3) and maintaining the enzymatic activity as seen in 
parental. 
The growth of the transgenic tachyzoites was monitored at 24 and 48 hours post-
infection from parasites that underwent less than three passages (early) or six passages 
(late) in culture (Fig. 3.4 A-D) to ensure that long passage in culture did not alter the 
expression of recombinant proteins and hence the effect of these proteins as suggested by 
Van et al. (2007).  It was observed that the growth of the parasites from early and late 
passages was unaffected and mirrored the growth of the parental strain.  The finding that 
the growth and enzymatic activity were unaffected with over-expression of either 
TgLDH1 or TgLDH2 suggests that the proteins did not increase the rate of glycolysis and 
energy production which would be associated with a higher growth rate.  Thus, it is likely 
that the proteins are playing a different role within the parasites.    
 
4.4 The over-expression of TgLDHs increases differentiation under alkaline 
media stress 
The conversion between the rapidly dividing tachyzoites and the slowly growing, 
encysted bradyzoites is an important event in the parasite life cycle.  TgLDH1 and 
TgLDH2 proteins have been used as markers for tachyzoites and bradyzoites, respectively 
(Weiss and Kim, 2000; Yang and Parmley, 1997).  The TgLDH1 mRNA is still present in 
bradyzoites, however the protein is replaced by TgLDH2.  Thus, it was important to study 
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the effect of TgLDH1 and TgLDH2 over-expression on differentiation.  Since the process 
of differentiation is poorly understood, it was necessary to verify that the observed cyst 
formation correlated to the presence of bradyzoite markers.  The bradyzoite specific 
antigen-1 (BAG1) was used as a control for bradyzoite formation (Bohne et al., 1995), 
and tubulin was used as a loading control.  As a positive control, the PLKΔHX strain was 
used, which is a type II laboratory strain that has a greater ability to differentiate as 
compared to type I parasites.  The RML2-mix strain is the original strain that was 
electroporated with TgLDH2, and used to clone individual parasites.  This strain was used 
as a test for differentiation.  Western blot analysis indicated that the marker appeared in 
bradyzoite samples that were grown in alkaline media for 5 days and was not present in 
tachyzoite samples (Fig. 3.5).  This indicated that when levels of cysts were visualized in 
transgenic parasites, the results correlated to bradyzoite formation.  
  A fluorescently labelled (FITC) Dolichos-lectin was used to monitor cyst 
formation (Fig. 3.6), which exhibited similar characteristics as observed by Dzierszinski 
et al. (2004).  Cyst formation was quantified by manually counting the number of 
vacuoles that formed cyst walls (Fig. 3.7).  It was observed that transgenic parasites over-
expressing either TgLDH1 or TgLDH2 formed nearly 50% more cyst structures than the 
parental RHΔHX.  Over-expressing an unrelated GFP protein produced ~12% of cyst, 
suggesting that the increased differentiation was a direct result of over-expressed 
TgLDHs.  Furthermore, the growth of parasites under alkaline conditions was halted in 
the transgenic clones, which is characteristic of cyst formation (Fig. 3.8).  It is not 
understood, however, why both TgLDH1 and TgLDH2 have a similar effect on the 
parasite’s ability to differentiate.  It is likely that post-transcriptional regulation is 
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important for the temporal and spatial regulation of TgLDH’s and over-expression may 
cause interference in this regulation.  Also, it is not known if differentiation causes the 
regulation of TgLDH’s or if the regulation affects the differentiation process.  By testing 
the parasite’s ability to spontaneously form cysts, without any alkaline stress, it was 
determined that the regulation likely relies on the differentiation process since an increase 
in spontaneous cyst formation was not observed.  Also, the parasite’s ability to convert 
back into tachyzoites once the stress was removed further suggests that TgLDHs may 
play a role in increasing cyst development under stress, but do not cause the parasites to 
remain encysted (Fig. 3.9).  It is important to note that the parental parasites form almost 
20% of cysts after 5 days in alkaline media.  After the parasites are returned to tachyzoite 
conditions for 48 hours, ~8% of vacuoles are still encysted.  Transgenic parasites, on the 
other hand, formed nearly 50% of encysted vacuoles after 5 days in alkaline media.  Once 
again, after returning the parasites to tachyzoite conditions for 48 hours, ~10% of 
vacuoles remain encysted.  Therefore, the presence of either over-expressed TgLDH1 or 
TgLDH2 increased the rate of reconversion from bradyzoites to tachyzoites.  Thus, not 
only is the conversion into bradyzoites increased under stress, but the reconversion into 
tachyzoites once the stress is removed is also increased. 
In conclusion, these studies are the first to suggest an important physiological 
function of TgLDH, in addition to being a glycolytic enzyme. To further determine the 
domains responsible for the function, one would perform deletion studies in which the 
substrate-, coenzyme-binding domains, or other truncated proteins can be assayed for 
their effects on the differentiation efficiency.  Also, immunoprecipitation assays could be 
performed to detect any proteins that the TgLDHs are interacting with to attempt to 
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elucidate any other pathways in which TgLDHs may have roles.  Finally, it would be 
interesting to measure the ability of these transgenic parasites to infect mice and form 
tissue cysts, to determine the differentiation ability in vivo.    
 
4.5 TgAgo_ChFP was successfully generated and localized 
The discovery of Toxoplasma gondii argonaute (TgAgo; Al Riyahi et al., 2006) 
suggested that there may be a functional RNA interference (RNAi) pathway within T. 
gondii.  It is also likely that TgAgo may play a role in other cellular functions in T. gondii 
as it does in many organisms (Carmell et al., 2002; Jaronczyk et al., 2005).  To study the 
role of TgAgo, a fusion with cherry fluorescent protein (ChFP) was generated (Appendix 
A).  ChFP was derived from a red fluorescent protein as a monomeric protein that excites 
at 587 nm and emits at 610 nm.  The benefits of using ChFP rather than GFP or RFP are 
that ChFP has a fast rate of maturation, high photostability, resistance to pH changes, and 
the ability to form stable N-terminal fusions within a cell (Shaner et al., 2004).  
Therefore, localization of TgAgo in the parasites is not likely to be compromised by the 
presence of ChFP.  
Parasites harbouring the TgAgo_ChFP fusion were identified both with western 
blot analyses and by fluorescence microscopy.  The anti-RFP antibody was able to be 
utilized since the ChFP protein is derived from RFP and the antibody was shown to cross 
react.  The western blot revealed a band at ~85 kDa as was expected since the molecular 
weight of TgAgo is ~58.5kDa, while that of ChFP is ~27kDa (Fig. 3.10).  There were two 
bands that were visualised for the TgAgo_ChFP sample that were nearly the same size.  It 
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is possible that the faint higher band is a phosphorylated form of TgAgo.  It has been 
shown that phosphorylation of human argonaute 2 plays a regulatory role in localizing 
argonaute 2 into processing bodies where degradation of messenger RNA occurs (Zeng et 
al., 2008).  Further studies of TgAgo would have to be performed to determine if 
phosphorylation is occurring for example by utilizing antibodies specific to 
phosphorylated forms of proteins.  On the other hand, the band shift may also be the 
result of a modification of ChFP or a possible degradation form of the fusion; however 
degradation is unlikely since the difference in size is minimal.  Fluorescence microscopy 
indicated that TgAgo_ChFP localizes mainly to the cytosol when compared to staining of 
the nuclei.  This finding is in agreement with localization studies of argonaute in other 
organisms.  The proper localization suggests that TgAgo_ChFP functions appropriately 
since it has been shown that localization is related to function (Sen and Blau, 2005).  The 
expression level and localization of the fusion protein could not be related to endogenous 
levels of argonaute due to a lack of antibody towards the endogenous protein.   
Further characterization of TgAgo_ChFP was attempted by using mass 
spectrometry.  The lysate of transgenic parasites was run on a western blot, transferred to 
a PVDF membrane, and the band corresponding to TgAgo_ChFP was excised and trypsin 
digested.  Unfortunately, the autolysis peaks of trypsin overlapped with peptide masses of 
TgAgo_ChFP, so identification was unsuccessful.  In order to properly utilize mass 
spectrometry, another enzyme, such as GluC, could be used for digestion to avoid the 
overlapping of peaks.  These peak sizes would differ since GluC cleaves after glutamic or 
aspartic acid residues, unlike trypsin which cleaves after lysine and arginine residues, thus 
these peaks would not overlap with important TgAgo_ChFP peaks.  Another possibility is 
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to enrich for the protein of interest by immunoprecipitation.  This would increase the 
amount of protein available for digestion by proteases.  If the number of generated 
peptides is increased, then the intensity of trypsin autolysis peaks decreases, allowing for 
isolation of specific peptides of interest and identification of the amino acid sequences.  
Immunoprecipitation of TgAgo_ChFP was attempted using the anti-RFP antibody bound 
to protein-A agarose beads, however the binding between the antibody and protein is 
weak, thus preventing successful immunoprecipitation.  Preliminary data suggested that 
either no protein bound, or very low levels bound (data not shown).  The former is more 
likely since silver staining of the SDS-PAGE gel did not show a band appearing at the 
expected size and this method of staining is very sensitive where its detection is in the 
nanogram scale (Chevallet et al., 2006). 
 
4.6 Differential expression of TgAgo alters the interconversion ability of T. gondii          
 Database mining revealed that mRNA levels of TgAgo vary among the three types 
of parasites, wherein type I parasites contain the highest levels of TgAgo (Fig. 3.12).  
Since type I parasites do not differentiate very well, it was hypothesized that TgAgo may 
play a role as a negative regulator of the process.  That is, higher levels of TgAgo may 
somehow prevent the parasite from successfully differentiating into bradyzoites.  This 
hypothesis was tested by studying the differentiation ability of three strains of parasites:  
transgenic parasites over-expressing TgAgo_ChFP, a null mutant of TgAgo (AgoKO), 
and a parental RHΔHX strain.  It was observed that both the TgAgo_ChFP and AgoKO 
strains could differentiate more than RHΔHX.  The cyst structures observed with FITC-
conjugated Dolichos-lectin are similar to the cyst structures observed in over-expressed 
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TgLDH parasites (Fig. 3.6 and 3.13).  Quantification of the cyst structures was performed 
as previously described, and showed that AgoKO parasites formed ~65% of cysts versus 
~14% in the parental RHΔHX (Fig. 3.14).  This result suggests that TgAgo plays a 
significant role by preventing parasites from differentiating.  One concern is from the 
generation of the AgoKO strain.  The TgAgo genomic sequence is ~4,500 bp in length.  
In order to generate the knockout, approximately a 6.5 kb region of sequence was deleted.  
A putative long chain fatty acid CoA ligase gene and two hypothetical proteins are 
located on either end of TgAgo.  Deletion of any part of these genes may be attributed to 
the phenotypes observed.  Therefore, these studies must be performed in another 
knockout strain to be generated by deleting a smaller fragment of TgAgo which would 
ensure that no other putative or hypothetical genes are interrupted.   
It was unexpected that the over-expression of TgAgo_ChFP formed just under 
40% of cysts that correlate with cherry fluorescence (Fig. 3.13, 3.14).  Moreover, it was 
expected that over-expression of the fusion would result in the differentiation ability to 
resemble or be lower than parental levels.  These results suggest that over-expressing 
TgAgo may somehow counter-effect the protection against cyst formation.  It is possible 
that the large ChFP tag may interfere with proper TgAgo function if it interrupts proper 
associations with other proteins, thus causing differentiation to increase.  Furthermore, 
recent database mining has revealed new available data for microarray studies of TgAgo 
that show similar levels of TgAgo between type I and type II parasites (http://toxodb.org; 
April 2009), as opposed to the higher levels in type I that were observed in previous 
database mining efforts.  These new experiments had used two different strains of 
parasites for each type to show reproducibility within a lineage.  Also, these experiments 
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were performed with better controls in that all parasites were harvested together at a 
similar confluency, the RNA samples were prepared at the same time, and all 
hybridizations were performed by one technician.  The current studies were based on the 
previous microarray results that suggested that TgAgo may play a role in differentiation.  
The altered differentiation ability that was observed between the mutant TgAgo strains 
fits the initial hypothesis.  Thus although the new data indicates that levels of TgAgo do 
not actually differ, TgAgo likely has a role in the pathway.  To further validate the levels 
of TgAgo mRNA, real time PCR should be performed so that more definitive correlations 
between TgAgo expression and differentiation can be made.   
 
4.7 Argonaute plays a role in a putative gene knockdown pathway in T. gondii 
 Identification of key players of the RNA interference pathway in the 
apicomplexan T. brucei led to elucidation of a similar pathway in T. gondii.  Recently, an 
argonaute protein was identified in T. gondii, and gene knockdown was observed after 
introduction of double stranded RNA (Al-Anouti et al., 2004).  It was of interest to 
identify a direct correlation between TgAgo and dsRNA induced gene knockdown.  The 
over-expressed and knockout lines of TgAgo were utilized to determine if the ability to 
knockdown UPRT was affected.  RH parasites were used as a control for knockdown 
levels, and it was determined that a maximum knockdown of ~60% was observed when 
using ~20 µg of dsRNA (Fig. 3.15).  The same experiment was repeated using the 
AgoKO and TgAgo_ChFP strains where a range of dsRNA concentrations were 
electroporated into the parasites.  It was observed that no significant knockdown was seen 
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in either strain (Fig. 3.16).  Knockout or knockdown of argonaute in other organisms 
resulted in a large reduction of RNAi activity suggesting that argonaute plays a key role 
in RNAi (Durand-Dubief and Bastin, 2003).  The lack of RNAi activity in the AgoKO 
strain suggests that TgAgo also plays a key role in the gene knockdown pathway of T. 
gondii.  If the knockdown had been a result of non-specific degradation, then knocking 
out TgAgo would not have affected the results.  However, since knockdown was no 
longer visible in the AgoKO strain, it is suggested that TgAgo plays a role and the 
degradation is sequence specific.  In the over-expressed strain, an inability to successfully 
knockdown UPRT was also observed.  It is possible that the large cherry tag interferes 
with RISC formation that may be required for a functional RNAi pathway.  To overcome 
this problem, a different tag such as a Myc or FLAG tag should be used that is smaller in 
size and would not interfere with protein-protein interactions.  An N-terminal fusion that 
contains the cherry fluorescent protein on the N-terminal of TgAgo was generated to 
determine if the position of cherry caused the fusion to act as an inhibitory protein in 
proper RISC formation (Appendix C).  Therefore, this fusion should be tested in the 
future in its ability to differentiate and perform double stranded induced gene silencing.  
It would also be interesting to determine if the observations made in these studies are the 
direct result of altered levels of endogenous argonaute.  Several clones of the fusion 
parasite should be tested since random integration may interfere with other genes causing 
some of the mentioned phenotypes.  Thus it is necessary to ensure that the results with the 
fusion strain were not merely artifacts.              
 
4.8 Altered levels of TgAgo affect the expression levels of putative dicer proteins  
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 It was of interest to determine if the expression of putative dicer proteins differed 
in parasites that had altered TgAgo levels.  To do so, an antibody raised against the 
RNaseIII domain of dicer was used in western blot analysis (Fig. 3.17).  It was observed 
that the expression of two putative dicer proteins at ~120 kDa and ~70 kDa was 
downregulated in the AgoKO strain, while expression of a putative dicer protein at ~40 
kDa was upregulated in the AgKO strain, as compared to parental.  These results suggest 
that the proteins may be involved in the same pathway since expression of one affects the 
expression of the other, or that upregulation of an RNaseIII domain containing protein is 
compensating for the loss of argonaute.  Full identification of the putative dicer proteins 
was attempted by immunoprecipitation assays which would be used in conjunction with 
mass spectrometry, unfortunately, very low levels were observed in the pre-clear sample 
and no proteins were pulled down (Fig. 3.18).  Optimization and possible enrichment 
experiments are required in further analyses to elucidate the proteins and their functions.  
Also, putative dicer proteins, as detected by database mining can be cloned and over-
expressed in T. gondii to measure the resulting phenotypes to further determine if the 
protein products participate in an RNAi-like mechanism.       
 
4.9 Conclusions 
 Studies of the pathologically important T. gondii focused on the lactate 
dehydrogenase enzyme in the interconversion pathway, and on argonaute’s possible role 
in both interconversion and gene knockdown.  It was observed that although the over-
expression of TgLDH1 or TgLDH2 did not change the overall enzymatic activity, 
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increase growth of tachyzoites, or yield a more virulent parasite strain, a significant in 
vitro differentiation to bradyzoites was detected after increased TgLDH1 or TgLDH2 
expression.  It was also observed that TgAgo may play a role in differentiation since mis-
regulation of the protein expression results in an increase in bradyzoite formation.  
Finally, the knockout of TgAgo failed to produce an RNAi response suggesting that 
TgAgo plays a critical role in the pathway since the pathway cannot occur without its 
presence.  The lack of gene knockdown in the over-expressed TgAgo_ChFP strain may 
be due to the large cherry tag interfering with RISC formation, thus halting the process.  
Finally, altered levels of argonaute expression significantly alter expression of putative 
dicer proteins suggesting that these proteins may participate in the same pathway.       
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Appendices 
Appendix A 
A.1 Generation and identification of Toxoplasma gondii argonaute fused to a cherry 
fluorescent protein  
In order to study the argonaute protein in Toxoplasma gondii (TgAgo) four strains of 
parasites were used: parental RH or RHΔHX strains, a TgAgo null mutant (obtained from Dr. 
Boothroyd, Stanford University School of Medicine), and a transgenic line over-expressing 
TgAgo_ChFP.  The TgAgo_ChFP fusion protein was generated by utilizing a plasmid that 
contained the cherry fluorescence protein driven by a T. gondii tubulin promoter 
(pTub_eGFP_mChFP).  The plasmid was digested with NheI and BglII to excise the GFP 
gene.  The vector backbone was then extracted from an agarose gel, and used for the ligation 
reaction.   
A.2 Preparation of TgAgo coding sequence 
To acquire the coding sequence of TgAgo containing restriction sites that were 
compatible with the vector, the sequence was PCR amplified using oligonucleotides which 
incorporated the NheI and BglII sites on either end, and the PCR fragment was ligated into a 
pBluescript plasmid.  This plasmid was transformed into E. coli cells and used for blue/white 
screening to identify clones that contained the target gene.  The plasmid was confirmed by 
digestion with PvuII and XhoI (Fig. A.1) and further digested with NheI and BglII (Fig. A.1) to 
obtain the TgAgo coding sequence which was extracted from an agarose gel, ligated with the 
pTub_ChFP vector, and transformed into E. coli.  PCR amplification of an 800 bp fragment 
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using internal oligonucleotides confirmed the presence of TgAgo in the isolated plasmids (Fig. 
A.1).    
A.3 Confirmation of the pTubTgAgo_ChFP plasmid by restriction digestion and 
DNA sequencing 
To ensure that TgAgo had been ligated into the vector in the correct orientation, 
restriction digestions were performed using XhoI and PvuII (Fig A.2), which produced the 
correct banding patterns.  The plasmid DNA was sent to Genome Quebec Innovation Centre 
(Montreal, Quebec) for DNA sequencing analysis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101 
 
A       B 
 
 
 
 
 
 
 
 
 
 
C 
 
 
 
 
 
 
 
 
Figure A.1 Isolation of TgAgo and generation of TgAgo_ChFP.  (A) Confirmation of 
the pBlueScript_TgAgo plasmid by digestion of the plasmid with PvuII and XhoI.  The 
undigested plasmid was run as a control.  (B) The pBlusk_TgAgo plasmid was doubly 
digested with NheI and BglII to isolate and extract the TgAgo coding sequence at 1581 bp 
which was further used for ligation reactions.  (C) The pTubTgAgo_ChFP plasmid was used 
as a template for PCR amplification using internal oligonucleotides that amplify an 800 bp 
fragment from TgAgo.  The pTubGFP_mChFP plasmid was used as a negative control.  
Approximate sizes are indicated on the left.  
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Figure A.2 Confirmation of pTubTgAgo_ChFP plasmid by restriction digestion. (A) 
XhoI and (B) PvuII enzymes were used to confirm the construction of the plasmid.  
Approximate sizes are indicated on the left.  The correct banding patterns were obtained.   
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Appendix B 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feature Location (bp) 
F1_ORI 1 – 457 
Tub8 Eukaryotic Promoter 656 – 1146  
Myc Epitope Tag 1172 – 1201  
TgLDH1 ORF 1246 – 2238  
SAG1 3’-UTR 2241 – 2541  
TgHXGPRT Cassette 2586 – 4467  
Plac Prokaryotic Promoter 4534 – 4655  
ColE1_ORI  4749 – 5612 
APr CDS  5693 – 6550  
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Feature Location (bp) 
F1_ORI 1 – 457  
Tub8 Eukaryotic Promoter 656 – 1146  
Myc Epitope Tag 1172 – 1201  
TgLDH2 CDS 1205 – 2224  
SAG1 3’-UTR 2228 – 2528  
TgHXGPRT Cassette 2573 – 4454  
Plac Prokaryotic Promoter 4521 – 4642  
ColE1_ORI  4736 – 5599  
APr CDS  5680 – 6537  
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Feature Location (bp) 
(mutated) F1 (+) ORI 1 – 457 
APr CDS  588 – 1447 
ColE1 ORI 1526 – 2389  
(mutated) Plac 2483 – 2605 
SagCATSag cassette 2730 – 4067 
Tub8 Promoter 4126 – 6842 
TgAgo CDS 6832 – 8430 
CherryFP CDS 8439 – 9143 
3’ DHFR UTR 9156 – 9908 
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Feature Location (bp) 
(mutated) F1 (+) ORI 1 – 457 
APr CDS  588 – 1447 
ColE1 ORI 1526 – 2389  
(mutated) Plac 2483 – 2605 
SagCATSag cassette 2730 – 4067 
Tub8 Promoter 4126 – 6842 
CherryFP CDS 6858 – 7565  
TgAgo CDS 7576 – 9156  
3’ DHFR UTR 9165 – 9917 
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Appendix C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C.1 Identification of an N-terminal fusion of ChFP_TgAgo.  Western blot 
analysis was used to identify the expression of the N-terminal fusion of ChFP_TgAgo in T. 
gondii.  The anti-RFP antibody was used to reveal a band at 85 kDa that corresponded to the 
fusion.  The band at 27 kDa corresponds to a cherry cleavage and RH was used as a negative 
control. 
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